e10vq
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2006
OR
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-815
E. I. du Pont de Nemours and Company
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
(State or other Jurisdiction of
Incorporation or Organization)
|
|
51-0014090
(I.R.S. Employer
Identification No.) |
1007 Market Street, Wilmington, Delaware 19898
(Address of Principal Executive Offices)
(302) 774-1000
(Registrants Telephone Number)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes X No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act. (Check one):
Large
Accelerated Filer X Accelerated
Filer Non-Accelerated Filer
Indicate by check mark whether the Registrant is a shell company (as defined by Rule12b-2 of the
Exchange Act).
Yes No X
919,803,822 shares (excludes 87,041,427 shares of treasury stock) of common stock, $0.30 par value,
were outstanding at October 16, 2006.
E. I. DU PONT DE NEMOURS AND COMPANY
Table of Contents
The terms DuPont or the company as used herein refer to E. I. du Pont de Nemours and Company
and its consolidated subsidiaries, or to E. I. du Pont de Nemours and Company, as the context may
indicate.
2
Part I. Financial Information
Item 1. CONSOLIDATED FINANCIAL STATEMENTS
E. I. DU PONT DE NEMOURS AND COMPANY AND CONSOLIDATED SUBSIDIARIES
Consolidated Income Statements (Unaudited)
(Dollars in millions, except per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
Net sales |
|
$ |
6,309 |
|
|
$ |
5,870 |
|
|
$ |
21,145 |
|
|
$ |
20,812 |
|
Other income, net |
|
|
336 |
|
|
|
438 |
|
|
|
1,002 |
|
|
|
1,444 |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
6,645 |
|
|
|
6,308 |
|
|
|
22,147 |
|
|
|
22,256 |
|
|
|
|
|
|
|
|
|
|
Cost of goods sold and other operating charges |
|
|
4,762 |
|
|
|
4,709 |
|
|
|
15,326 |
|
|
|
14,980 |
|
Selling, general and administrative expenses |
|
|
756 |
|
|
|
751 |
|
|
|
2,400 |
|
|
|
2,424 |
|
Amortization of intangible assets |
|
|
57 |
|
|
|
57 |
|
|
|
172 |
|
|
|
171 |
|
Research and development expense |
|
|
320 |
|
|
|
324 |
|
|
|
961 |
|
|
|
976 |
|
Interest expense |
|
|
114 |
|
|
|
140 |
|
|
|
347 |
|
|
|
364 |
|
Separation
activities - Textiles & Interiors |
|
|
- |
|
|
|
(23 |
) |
|
|
- |
|
|
|
(62 |
) |
|
|
|
|
|
|
|
|
|
Total |
|
|
6,009 |
|
|
|
5,958 |
|
|
|
19,206 |
|
|
|
18,853 |
|
|
|
|
|
|
|
|
|
|
Income before income taxes and minority interests |
|
|
636 |
|
|
|
350 |
|
|
|
2,941 |
|
|
|
3,403 |
|
Provision for income taxes |
|
|
152 |
|
|
|
435 |
|
|
|
662 |
|
|
|
1,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority interests in earnings (losses) of consolidated
subsidiaries |
|
|
(1 |
) |
|
|
(3 |
) |
|
|
2 |
|
|
|
42 |
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
485 |
|
|
$ |
(82 |
) |
|
$ |
2,277 |
|
|
$ |
1,900 |
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share of common stock |
|
$ |
0.52 |
|
|
$ |
(0.09 |
) |
|
$ |
2.46 |
|
|
$ |
1.90 |
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share of common stock |
|
$ |
0.52 |
|
|
$ |
(0.09 |
) |
|
$ |
2.44 |
|
|
$ |
1.89 |
|
|
|
|
|
|
|
|
|
|
Dividends per share of common stock |
|
$ |
0.37 |
|
|
$ |
0.37 |
|
|
$ |
1.11 |
|
|
$ |
1.09 |
|
|
|
|
|
|
|
|
|
|
See pages 6-25 for Notes to Consolidated Financial Statements.
3
E. I.
du Pont de Nemours and Company
Consolidated Balance Sheets (Unaudited)
(Dollars in millions, except per share)
|
|
|
|
|
|
|
|
|
|
|
September 30, 2006 |
|
December 31, 2005 |
Assets |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
718 |
|
|
$ |
1,736 |
|
Marketable debt securities |
|
|
6 |
|
|
|
115 |
|
Accounts and notes receivable, net |
|
|
6,586 |
|
|
|
4,801 |
|
Inventories |
|
|
4,809 |
|
|
|
4,743 |
|
Prepaid expenses |
|
|
192 |
|
|
|
199 |
|
Income taxes |
|
|
763 |
|
|
|
828 |
|
|
|
|
|
|
Total current assets |
|
|
13,074 |
|
|
|
12,422 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net of accumulated
depreciation (September 30, 2006 - $15,190;
December 31, 2005 - $14,654) |
|
|
10,406 |
|
|
|
10,309 |
|
Goodwill |
|
|
2,118 |
|
|
|
2,087 |
|
Other intangible assets |
|
|
2,627 |
|
|
|
2,684 |
|
Investment in affiliates |
|
|
855 |
|
|
|
844 |
|
Other assets |
|
|
5,100 |
|
|
|
4,904 |
|
|
|
|
|
|
Total |
|
$ |
34,180 |
|
|
$ |
33,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
2,401 |
|
|
$ |
2,819 |
|
Short-term borrowings and capital lease obligations |
|
|
3,242 |
|
|
|
1,397 |
|
Income taxes |
|
|
318 |
|
|
|
280 |
|
Other accrued liabilities |
|
|
2,770 |
|
|
|
2,967 |
|
|
|
|
|
|
Total current liabilities |
|
|
8,731 |
|
|
|
7,463 |
|
|
|
|
|
|
|
|
|
|
Long-term borrowings and capital lease obligations |
|
|
5,509 |
|
|
|
6,783 |
|
|
|
|
|
|
|
|
|
|
Other liabilities |
|
|
8,162 |
|
|
|
8,441 |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes |
|
|
1,184 |
|
|
|
1,166 |
|
|
|
|
|
|
Total liabilities |
|
|
23,586 |
|
|
|
23,853 |
|
|
|
|
|
|
Minority interests |
|
|
473 |
|
|
|
490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders equity |
|
|
|
|
|
|
|
|
Preferred stock |
|
|
237 |
|
|
|
237 |
|
Common stock, $0.30 par value; 1,800,000,000 shares
authorized;Issued and outstanding at September 30,
2006 - 1,006,569,870; December 31, 2005 - 1,006,651,566 |
|
|
302 |
|
|
|
302 |
|
Additional paid-in capital |
|
|
7,671 |
|
|
|
7,678 |
|
Reinvested earnings |
|
|
9,097 |
|
|
|
7,935 |
|
Accumulated other comprehensive loss |
|
|
(459 |
) |
|
|
(518 |
) |
Common stock held in treasury, at cost (Shares:
September 30, 2006 and December 31, 2005 - 87,041,427) |
|
|
(6,727 |
) |
|
|
(6,727 |
) |
|
|
|
|
|
Total stockholders equity |
|
|
10,121 |
|
|
|
8,907 |
|
|
|
|
|
|
Total |
|
$ |
34,180 |
|
|
$ |
33,250 |
|
|
|
|
|
|
See pages 6-25 for Notes to Consolidated Financial Statements.
4
E. I. du Pont de Nemours and Company
Consolidated Statements of Cash Flows (Unaudited)
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
|
2006 |
|
|
2005 |
|
Operating activities |
|
|
|
|
|
|
|
|
Net income |
|
$ |
2,277 |
|
|
$ |
1,900 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation |
|
|
866 |
|
|
|
840 |
|
Amortization of intangible assets |
|
|
172 |
|
|
|
171 |
|
Separation activities - Textiles & Interiors |
|
|
- |
|
|
|
(62 |
) |
Contributions to pension plans |
|
|
(226 |
) |
|
|
(1,213 |
) |
Other operating activities - net |
|
|
115 |
|
|
|
(380 |
) |
Change in operating assets and liabilities - net |
|
|
(2,441 |
) |
|
|
(1,427 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash provided by (used for) operating activities |
|
|
763 |
|
|
|
(171 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment |
|
|
(1,085 |
) |
|
|
(868 |
) |
Investments in affiliates |
|
|
(22 |
) |
|
|
(54 |
) |
Payments for businesses - net of cash acquired |
|
|
(57 |
) |
|
|
(142 |
) |
Proceeds from sales of assets - net of cash sold |
|
|
80 |
|
|
|
331 |
|
Net decrease (increase) in short-term financial instruments |
|
|
110 |
|
|
|
(37 |
) |
Forward exchange contract settlements |
|
|
50 |
|
|
|
289 |
|
Other investing activities - net |
|
|
27 |
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash used for investing activities |
|
|
(897 |
) |
|
|
(495 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
|
Dividends paid to stockholders |
|
|
(1,035 |
) |
|
|
(1,095 |
) |
Net increase in borrowings |
|
|
472 |
|
|
|
4,242 |
|
Acquisition of treasury stock |
|
|
(280 |
) |
|
|
(505 |
) |
Proceeds from exercise of stock options |
|
|
45 |
|
|
|
347 |
|
Other financing activities - net |
|
|
(82 |
) |
|
|
(33 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash (used for) provided by financing activities |
|
|
(880 |
) |
|
|
2,956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
(4 |
) |
|
|
(512 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Decrease) Increase in cash and cash equivalents |
|
$ |
(1,018 |
) |
|
$ |
1,778 |
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of period |
|
|
1,736 |
|
|
|
3,369 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
718 |
|
|
$ |
5,147 |
|
|
|
|
|
|
|
|
See pages 6-25 for Notes to Consolidated Financial Statements.
5
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 1. Summary of Significant Accounting Policies
Interim Financial Statements
The accompanying unaudited consolidated financial statements have been prepared in accordance with
accounting principles generally accepted in the United States of America (U.S.) for interim
financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the
opinion of management, all adjustments (consisting of normal recurring adjustments) considered
necessary for a fair statement of the results for interim periods have been included. Results for
interim periods should not be considered indicative of results for a full year. These interim
consolidated financial statements should be read in conjunction with the Consolidated Financial
Statements and notes thereto contained in the companys Annual Report on Form 10-K for the year
ended December 31, 2005. The Consolidated Financial Statements include the accounts of the company
and all of its subsidiaries in which a controlling interest is maintained, as well as variable
interest entities in which DuPont is considered the primary beneficiary. Certain reclassifications
of prior years data have been made to conform to current year classifications.
Accounting Standards Issued Not Yet Adopted
In June 2006, the Financial Accounting Standards Board (FASB) issued FASB Interpretation No. 48
Accounting for Uncertainty in Income Taxes an interpretation of FASB Statement No. 109
Accounting for Income Taxes. The interpretation clarifies the accounting for uncertainty in
income taxes recognized in financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. This statement becomes effective for the company
beginning in the first quarter of 2007. The company is currently evaluating the impact of its
adoption on its consolidated financial statements.
In September 2006, the FASB issued FASB Staff Position (FSP) AUG AIR-1, Accounting for Planned
Major Maintenance Activities, which prohibits the use of the accrue-in-advance method, effective
the first fiscal year beginning after December 15, 2006. The company principally accrues in advance
for significant planned maintenance activities and expects to change to the defer and amortize
method upon adoption of the FSPs provisions. The FSP requires retrospective application and
recognition of the cumulative effect of the change in retained earnings at the beginning of the
first period presented. The company is currently evaluating the impact of adopting this FSP on its
consolidated financial statements. Management does not currently believe that adoption of this FSP
will have a material effect on the companys financial position, liquidity or results of
operations.
In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 157,
Fair Value Measurements. This statement clarifies the definition of fair value, establishes a
framework for measuring fair value, and expands the disclosures on fair value measurements. SFAS
No. 157 is effective for fiscal years beginning after November 15, 2007. The company is currently
evaluating the impact of its adoption on its consolidated financial statements.
In September 2006, the FASB issued SFAS No. 158, Employers Accounting for Defined Benefit Pension
and Other Postretirement Plans an amendment of FASB Statements No. 87, 88, 106, and 132(R). As
required by SFAS No. 158, the company will prospectively adopt
SFAS No. 158 on December 31, 2006.
Upon adoption, the company will include in Stockholders equity, accumulated other comprehensive
income, net of tax, actuarial gains and losses and prior service costs and credits, that pursuant
to SFAS No. 87 and 106 have not been recognized as components of net periodic benefit cost. The
company will also recognize in its statement of financial position an asset or a liability that
represents the funded status of its defined benefit postretirement plans. These amounts are
significantly dependent on pension contributions during the remainder of 2006, and on the fair
market value of plan assets and discount rates at December 31, 2006. These latter two factors are
critical for determining the unfunded benefit obligations, and are heavily influenced by the
external stock market and interest rate environment at December 31, 2006. To determine the effect
of SFAS No. 158, each of the companys plans must be evaluated individually.
6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Accordingly, estimating the effect on the companys financial statements is subject to material
change from current expectations. However, based on current expectations, the company reasonably
estimates that the effect of adopting SFAS No. 158 on Stockholders equity is between $1,400 to
$2,900, after-tax. The table below presents the range of effects on the asset, liability and
stockholders equity accounts presented in the companys consolidated financial statements.
|
|
|
|
|
|
|
|
|
(Dollars in billions) |
|
Range |
|
|
Low |
|
High |
Change in net assets |
|
|
|
|
|
|
|
|
Decrease in prepaid pension asset included in other assets |
|
$ |
(3.3 |
) |
|
$ |
(3.3 |
) |
Decrease/(increase)
in accrued pension and other
postretirement benefits included in other liabilities |
|
|
0.9 |
|
|
|
(1.1 |
) |
Increase in net deferred tax assets |
|
|
1.0 |
|
|
|
1.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in net assets |
|
$ |
(1.4 |
) |
|
$ |
(2.9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decrease in stockholders equity |
|
$ |
(1.4 |
) |
|
$ |
(2.9 |
) |
|
|
|
|
|
|
|
SFAS No. 158 will have no impact on the measurement of cost for the companys defined benefit plans
or on the December 31 measurement date.
In September 2006, the Securities and Exchange Commission staff issued Staff Accounting Bulletin
No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in
Current Year Financial Statements (SAB 108). Traditionally, there have been two widely-recognized
methods for quantifying the effects of financial statement misstatements: the roll-over method
and the iron curtain method. The roll-over method focuses primarily on the impact of a
misstatement on the income statementincluding the reversing effect of prior year
misstatementsbut its use can lead to the accumulation of misstatements in the balance sheet. The
iron-curtain method focuses primarily on the effect of correcting the period-end balance sheet with
less emphasis on the reversing effects of prior year errors on the income statement.
SAB 108 establishes a dual approach to quantification of financial statement misstatements that
requires quantification under both the iron curtain and the roll-over methods. SAB 108 permits
existing public companies to initially apply its provisions by recording the cumulative effect of
applying the dual approach as adjustments to the carrying values of assets and liabilities as of
January 1, 2006, with an offsetting adjustment recorded to the opening balance of retained
earnings. The company is currently evaluating the impact of its adoption on the consolidated
financial statements.
Note 2. Stock-Based Compensation
The DuPont Stock Performance Plan provides for long-term incentive grants of stock options,
time-vested restricted stock units, and performance-based restricted stock units to key employees.
Effective January 1, 2006, the company adopted SFAS No. 123(R), Share-Based Payment, using the
modified prospective application transition method. Because the company adopted the fair value
recognition provisions of SFAS No. 123, Accounting for Stock-Based Compensation, as amended,
prospectively on January 1, 2003, the adoption of SFAS No. 123(R) did not have a material impact on
the companys financial position or results of operations. Prior to adoption of SFAS No. 123(R),
the nominal vesting approach was followed for all awards. Upon adoption of SFAS No. 123(R) on
January 1, 2006, the company began expensing new stock-based compensation awards using a
non-substantive approach, under which compensation costs are recognized over at least six months
for awards granted to employees who are retirement eligible at the date of the grant or would
become retirement eligible during the vesting period of the grant. Using the non-substantive
vesting approach in lieu of the nominal vesting approach would not have had a material impact on
the companys results of operations. Prior to the
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
adoption of SFAS No. 123(R), the company reported
the tax benefit of stock option exercises as operating cash flows. Upon the adoption of SFAS No.
123(R), tax benefits resulting from tax deductions in excess of compensation cost recognized for
those options or restricted stock units are reported as financing cash flows rather than as a
reduction of taxes paid.
The total stock-based compensation cost included in the Consolidated Income Statements was $31 and
$120, respectively, and $10 and $39 of income tax benefits related to stock-based compensation
arrangements in the three and nine months ended September 30, 2006. The total stock-based
compensation cost included in the Consolidated Income Statements was $24 and $66, respectively, and
$7 and $20 of income tax benefits related to stock-based compensation arrangements in the three and
nine months ended September 30, 2005.
The maximum number of shares that may be granted subject to option or in the form of time-vested
and performance-based restricted stock units for any consecutive five-year period is 72 million
shares. Of the 72 million shares, 12 million may be in the form of time-vested and/or
performance-based restricted stock units. At December 31, 2005, approximately 42 million shares
were authorized for future grant under the companys plan. The companys Compensation Committee
determines the long-term incentive mix, including stock options, time-vested and performance-based
restricted stock units, and may authorize new grants annually.
Stock Options
The company grants stock option awards under the DuPont Stock Performance Plan. The purchase price
of shares subject to option is equal to the market price of the companys stock on the date of
grant. Prior to 2004, options expired 10 years from date of grant; however, beginning in 2004,
options serially vest over a three-year period and carry a six-year option term. The plan allows
retirement eligible employees to retain any granted awards upon retirement provided the employee
has rendered at least six months of service following grant date.
For purposes of determining the fair value of stock options awards, the company uses the
Black-Scholes option pricing model and the assumptions set forth in the table below. The
weighted-average grant-date fair value of options granted in the nine months ended September 30,
2006 was $7.28. The company did not grant any options during the third quarter of 2006. The
weighted-average grant-date fair value of options granted in the three and nine months ended
September 30, 2005 was $7.13 and $8.79, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
Dividend yield |
|
|
* |
|
|
|
3.4 |
% |
|
|
3.8 |
% |
|
|
2.9 |
% |
Volatility |
|
|
* |
|
|
|
22.23 |
% |
|
|
25.03 |
% |
|
|
23.36 |
% |
Risk free interest rate |
|
|
* |
|
|
|
3.8 |
% |
|
|
4.4 |
% |
|
|
3.7 |
% |
Expected life (years) |
|
|
* |
|
|
|
4.50 |
|
|
4.50 |
|
|
4.50 |
|
|
|
* |
|
There were no stock options granted in the third quarter of 2006, therefore the Black-Scholes
pricing model and assumptions were not calculated for this period. |
The company determines the dividend yield by dividing the current annual dividend on the
companys stock by the option exercise price. A historical daily measurement of volatility is
determined based on the expected life of the option granted. The risk free interest rate is
determined by reference to the yield on an outstanding U.S. Treasury note with a term equal to the
expected life of the option granted. Expected life is determined by reference to the companys
historical experience.
8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Stock Option awards as of September 30, 2006 and changes during the three and nine month
periods then ended were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
Weighted Average |
|
|
|
|
Number of |
|
Average |
|
Remaining |
|
Aggregate |
|
|
Shares |
|
Exercise |
|
Contractual Term |
|
Intrinsic Value |
|
|
(in thousands) |
|
Price |
|
(years) |
|
(in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2005 |
|
|
92,943 |
|
|
$ |
46.90 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
6,140 |
|
|
$ |
39.30 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(435 |
) |
|
$ |
37.96 |
|
|
|
|
|
|
|
|
|
Canceled |
|
|
(1,946 |
) |
|
$ |
43.01 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(71 |
) |
|
$ |
43.34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, March 31, 2006 |
|
|
96,631 |
|
|
$ |
46.54 |
|
|
|
4.34 |
|
|
$ |
74,409 |
|
Granted |
|
|
34 |
|
|
$ |
41.29 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(578 |
) |
|
$ |
39.20 |
|
|
|
|
|
|
|
|
|
Canceled |
|
|
(129 |
) |
|
$ |
49.07 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(121 |
) |
|
$ |
42.36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, June 30, 2006 |
|
|
95,837 |
|
|
$ |
46.58 |
|
|
|
4.08 |
|
|
$ |
59,480 |
|
Granted |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(126 |
) |
|
$ |
37.65 |
|
|
|
|
|
|
|
|
|
Canceled |
|
|
(139 |
) |
|
$ |
43.99 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(57 |
) |
|
$ |
42.49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, September 30, 2006* |
|
|
95,515 |
|
|
$ |
46.60 |
|
|
|
3.83 |
|
|
$ |
87,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable, September 30, 2006 |
|
|
76,485 |
|
|
$ |
46.14 |
|
|
|
3.72 |
|
|
$ |
66,155 |
|
|
|
|
* |
|
Includes 12.5 million and 8.3 million options outstanding from the 2002 and 1997 grants of
200 shares to all eligible employees at an option price of $44.50 and $52.50, respectively. |
The aggregate intrinsic values in the table above represent the total pretax intrinsic value
(the difference between DuPonts closing stock price on the last trading day of the quarter of
fiscal 2006 and the exercise price, multiplied by the number of in-the-money options) that would
have been received by the option holders had all option holders exercised their options at quarter
end. The amount changes based on the fair market value of DuPonts stock. Total intrinsic value
of options exercised for the three and nine months ended September 30, 2006 were $1 and $5,
respectively. For the three and nine months ended September 30, 2005, the total intrinsic value of
options exercised was $5 and $157, respectively.
As of September 30, 2006, $48 of total unrecognized compensation cost related to stock options is
expected to be recognized over a weighted-average period of 1.5 years.
Time-vested and Performance-based Restricted Stock Units
In 2004, the company began issuing time-vested restricted stock units in addition to stock options.
These restricted stock units serially vest over a three-year period. Concurrently, stock option
terms were reduced from ten years to six years and the number of options granted was also reduced.
A retirement eligible employee retains any granted awards upon retirement provided the employee has
rendered at least six months of service following grant date. Additional restricted stock units
are also granted from time to time to key senior management employees. These restricted stock
units generally vest over periods ranging from two to five years.
9
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
The company also grants performance-based restricted stock units to senior leadership. Vesting
occurs upon attainment of pre-established corporate revenue growth and return on investment
objectives versus peer companies at the end of a three-year performance period. The actual award,
delivered as DuPont common stock, can range from zero percent to 200 percent of the original grant.
During the first nine months of 2006, there were 361,100 performance-based restricted stock units
granted at a weighted average grant date fair value of $39.31.
The fair value of time-vested and performance-based restricted stock units is based upon the market
price of the underlying common stock as of the date of the grant.
Nonvested awards of time-vested and performance-based restricted stock units as of September 30,
2006 and changes during the period then ended were as follows:
|
|
|
|
|
|
|
|
|
|
|
Number of |
|
Weighted-Average |
|
|
Shares |
|
Grant Date Fair |
|
|
(in thousands) |
|
Value |
|
|
|
|
|
|
|
|
|
Nonvested, December 31, 2005 |
|
|
2,086 |
|
|
$ |
45.59 |
|
Granted |
|
|
1,942 |
|
|
$ |
39.03 |
|
Vested |
|
|
(488 |
) |
|
$ |
45.44 |
|
Forfeited |
|
|
(7 |
) |
|
$ |
40.08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, March 31, 2006 |
|
|
3,533 |
|
|
$ |
41.69 |
|
Granted |
|
|
28 |
|
|
$ |
41.03 |
|
Vested |
|
|
(11 |
) |
|
$ |
40.80 |
|
Forfeited |
|
|
(57 |
) |
|
$ |
42.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, June 30, 2006 |
|
|
3,493 |
|
|
$ |
41.73 |
|
Granted |
|
|
|
|
|
$ |
|
|
Vested |
|
|
(11 |
) |
|
$ |
40.45 |
|
Forfeited |
|
|
(21 |
) |
|
$ |
40.82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested, September 30, 2006 |
|
|
3,461 |
|
|
$ |
41.75 |
|
The table above includes restricted stock units for the Board of Directors settled in cash.
As of September 30, 2006, there was $57 unrecognized stock-based compensation expense related to
nonvested awards. That cost is expected to be recognized over a weighted-average period of 1.8
years. The total fair value of shares vested during the three and nine months ended September 30,
2006, was less than $1 and $22, respectively. For the three and nine months ended September 30,
2005, the total fair value of shares vested was less than $1 and $10, respectively.
10
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 3. Other Income, Net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CozaarÒ/HyzaarÒ income |
|
$ |
209 |
|
|
$ |
196 |
|
|
$ |
576 |
|
|
$ |
544 |
|
Royalty income |
|
|
26 |
|
|
|
39 |
|
|
|
88 |
|
|
|
82 |
|
Interest income, net of miscellaneous interest expense |
|
|
29 |
|
|
|
58 |
|
|
|
98 |
|
|
|
189 |
|
Equity in earnings of affiliates |
|
|
16 |
|
|
|
24 |
|
|
|
47 |
|
|
|
92 |
|
Net gains on sales of assets |
|
|
25 |
|
|
|
30 |
|
|
|
28 |
|
|
|
82 |
|
Net exchange gains (losses)* |
|
|
(1 |
) |
|
|
68 |
|
|
|
20 |
|
|
|
346 |
|
Miscellaneous income and expenses - net |
|
|
32 |
|
|
|
23 |
|
|
|
145 |
|
|
|
109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
336 |
|
|
$ |
438 |
|
|
$ |
1,002 |
|
|
$ |
1,444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The company routinely uses forward exchange contracts to hedge its net
exposures, by currency, related to the foreign currency-denominated monetary
assets and liabilities of its operations. The objective of this program is to
maintain an approximately balanced position in foreign currencies in order to
minimize the effects of exchange rate changes on an after-tax basis. |
Note 4. Hurricane Related Matters
During the third quarter of 2006, the company received initial insurance recoveries from its
insurance carriers of $50 for damages sustained from hurricane Katrina in 2005. This amount was
recorded as a reduction to Cost of goods sold and other operating charges. Recoveries were $43 in
the Coatings & Color Technologies segment and $7 in Safety & Protection. While the Company
continues to pursue additional recoveries, substantially in excess of
the amount already received, the specific amount and timing of such recoveries, if any,
remains uncertain.
The company carries property damage and business interruption insurance, subject to deductible
amounts. Recoveries for losses incurred are recorded as a reduction to Cost of goods sold and other
operating charges. Cash proceeds related to the reimbursement for property damage are reflected in
Other investing activities. While all other proceeds are reflected in cash provided by operating
activities within the Companys Statements of Cash Flows.
In the third quarter of 2005, a charge of $146 was recorded related to the
clean-up and restoration of manufacturing operations, as well as the write-off of inventory and
plant assets that were destroyed by two major hurricanes in the U.S. Hurricane charges reduced
segment earnings as follows: Coatings & Color Technologies - $113; Performance Materials - $11;
and Safety & Protection - $22. These charges were included in Cost of goods sold and other
operating charges.
Note 5. Restructuring Charges
A business transformation plan was instituted during the first quarter 2006 within the Coatings &
Color Technologies segment to better serve the companys customers and improve profitability. The
plan includes the elimination of 1,700 positions and encompasses redeployment of employees in
excess positions to the extent possible. Restructuring charges resulting from the plan totaled
$135 and are included in Cost of goods sold and other operating charges. These charges include
$123 related to severance payments primarily in Europe and the U.S. for approximately 1,300
employees involved in manufacturing, marketing, administrative and technical activities. In
connection with this program, a $12 charge was also recorded related to exit costs of non-strategic
assets. As of September 30, 2006, approximately 475 employees were separated from the company and
approximately 300 were redeployed. Cash payments net of exchange impact on the reserve, related to
these separations were $19 as of September 30, 2006. All employees are expected to be off the rolls
by fourth quarter 2007. During the third quarter 2006, there were no changes in estimates related
to reserves established for restructuring initiatives recorded in the first quarter 2006.
11
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
The account balances and activity for the 2006 transformation plan are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee |
|
|
|
|
|
|
|
|
|
|
|
|
Separation |
|
|
Writedown |
|
|
Other Exit |
|
|
|
|
|
|
Costs |
|
of Assets |
|
Costs |
|
Total |
Net charges to income in 2006 |
|
$ |
123 |
|
|
$ |
11 |
|
|
$ |
1 |
|
|
$ |
135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charges to accounts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee separation settlements |
|
|
(19 |
) |
|
|
|
|
|
|
|
|
|
|
(19 |
) |
Asset write-offs |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at September 30, 2006 |
|
$ |
104 |
|
|
$ |
- |
|
|
$ |
1 |
|
|
$ |
105 |
|
|
|
|
|
|
|
|
|
|
Prior Year Corporate Programs
During the third quarter 2006, a benefit of $2 was recorded to reflect lower estimated benefit
settlements to separate employees for prior year restructuring programs. The change in estimate is
not considered material to 2006 segment earnings. A complete discussion of the prior years
activities is included in the companys Annual Report on Form 10-K for the year ended December 31,
2005 at Note 4, Employee Separation Costs and Asset Impairment Charges.
The account balance and activity for prior year programs are as follows:
|
|
|
|
|
Balance at December 31, 2005 |
|
$ |
55 |
|
Employee separation settlements |
|
|
(15 |
) |
Credits to income in 2006 |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
Balance at September 30, 2006 |
|
$ |
38 |
|
|
|
|
The remaining liability balance at September 30, 2006 represents payments to be made over time to
separated employees.
Note 6. Separation Activities - Textiles & Interiors
In January 2006, the company completed the sale of its interest in the last equity affiliate to its
equity partner for proceeds of $14 thereby completing the sale of all the net assets of Textiles &
Interiors.
In the third quarter of 2005, the company recorded a net gain of $20 ($13 after-tax) primarily
related to the sale of its investment in an equity affiliate to subsidiaries of Koch Industries,
Inc. (Koch). Year-to-date 2005 also included a net gain of $39 related to the sale of its
investment in an affiliated company to its equity partner for $110, and the completion of the
previously delayed transfer of its interest in two equity affiliates to subsidiaries of Koch,
partially offset by other costs associated with the separation of Textiles & Interiors.
12
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 7. Provision for Income Taxes
In the third quarter 2006, the company recorded a tax provision of $152 including $4 of tax expense
associated with the companys policy of hedging the foreign currency-denominated monetary assets
and liabilities of its operations. Year-to-date 2006 includes a net tax benefit of $41 related to
the reversal of certain prior year tax contingencies previously reserved, a tax benefit of $31
associated with an increase in the deferred tax assets of a European subsidiary for a tax basis
investment loss recognized on the local tax return and an additional $20 of tax expense associated
with the companys hedging policy.
In the third quarter 2005, the company recorded a tax provision of $435 including $320 of tax
expense related to the repatriation of $9,100 under the American Jobs Creation Act of 2004 (AJCA).
Also included in the third quarter of 2005 was $52 of tax expense associated with the companys
policy of hedging the foreign currency-denominated monetary assets and liabilities of its
operations. Year-to-date 2005 includes a tax benefit of $24 related to the reversal of certain
prior year tax contingencies previously reserved and an additional $344 of tax expense associated
with the companys hedging policy.
Note 8. Earnings (Losses) Per Share of Common Stock
Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings
per share calculations for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
485.3 |
|
|
$ |
(82.3 |
) |
|
$ |
2,276.8 |
|
|
$ |
1,900.1 |
|
Preferred dividends |
|
|
(2.5 |
) |
|
|
(2.5 |
) |
|
|
(7.5 |
) |
|
|
(7.5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to
common stockholders |
|
$ |
482.8 |
|
|
$ |
(84.8 |
) |
|
$ |
2,269.3 |
|
|
$ |
1,892.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average
number of common shares |
|
|
922,023,399 |
|
|
|
995,464,491 |
|
|
|
921,620,506 |
|
|
|
995,928,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dilutive effect of the companys
employee compensation plans
and accelerated share repurchase
agreement |
|
|
5,208,481 |
|
|
|
* |
|
|
|
7,189,004 |
|
|
|
6,650,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of common
shares Diluted |
|
|
927,231,880 |
|
|
|
995,464,491 |
|
|
|
928,809,510 |
|
|
|
1,002,579,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Not applicable as the company recorded a net loss for the three months ended September 30, 2005 . |
The following average stock options are antidilutive, and therefore, are not included in the
diluted earnings per share calculations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
Average Number of Stock Options |
|
|
80,303,545 |
|
|
|
69,975,674 |
|
|
|
72,251,062 |
|
|
|
45,455,399 |
|
13
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 9. Inventories
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
|
|
2006 |
|
2006 |
|
|
|
|
|
|
|
|
|
Finished products |
|
$ |
3,137 |
|
|
$ |
2,831 |
|
Semifinished products |
|
|
1,303 |
|
|
|
1,534 |
|
Raw materials and supplies |
|
|
896 |
|
|
|
863 |
|
|
|
|
|
|
|
|
|
5,336 |
|
|
|
5,228 |
|
|
|
|
|
|
|
|
|
|
Adjustment of inventories to a Last-In, First-Out (LIFO) basis |
|
|
(527 |
) |
|
|
(485 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,809 |
|
|
$ |
4,743 |
|
|
|
|
|
|
Note 10. Goodwill and Other Intangible Assets
Changes in goodwill for the period ended September 30, 2006 are summarized in the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of |
|
Adjustments |
|
Balance as of |
|
|
December 31, |
|
and |
|
September 30, |
Segment |
|
2005 |
|
Acquisitions |
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Agriculture & Nutrition |
|
$ |
607 |
|
|
$ |
1 |
|
|
$ |
608 |
|
Coatings & Color Technologies |
|
|
824 |
|
|
|
7 |
|
|
|
831 |
|
Electronic & Communication Technologies |
|
|
173 |
|
|
|
2 |
|
|
|
175 |
|
Performance Materials |
|
|
317 |
|
|
|
(5 |
) |
|
|
312 |
|
Safety & Protection |
|
|
154 |
|
|
|
26 |
1 |
|
|
180 |
|
Other |
|
|
12 |
|
|
|
- |
|
|
|
12 |
|
|
|
|
|
|
|
|
Total |
|
$ |
2,087 |
|
|
$ |
31 |
|
|
$ |
2,118 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Includes goodwill resulting from the acquisition of environmental technology businesses. |
The gross carrying amounts and accumulated amortization in total and by major class of other
intangible assets are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2006 |
|
December 31, 2005 |
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
Gross |
|
Amortization |
|
Net |
|
Gross |
|
Amortization |
|
Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets subject to
amortization (Definite-lived): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchased technology |
|
$ |
2,125 |
|
|
$ |
(1,237 |
) |
|
$ |
888 |
|
|
$ |
2,179 |
|
|
$ |
(1,217 |
) |
|
$ |
962 |
|
Patents |
|
|
177 |
|
|
|
(44 |
) |
|
|
133 |
|
|
|
176 |
|
|
|
(45 |
) |
|
|
131 |
|
Trademarks |
|
|
84 |
|
|
|
(21 |
) |
|
|
63 |
|
|
|
77 |
|
|
|
(18 |
) |
|
|
59 |
|
Other |
|
|
590 |
|
|
|
(207 |
) |
|
|
383 |
|
|
|
550 |
|
|
|
(176 |
) |
|
|
374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,976 |
|
|
|
(1,509 |
) |
|
|
1,467 |
|
|
|
2,982 |
|
|
|
(1,456 |
) |
|
|
1,526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets not subject to
amortization (Indefinite-lived): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trademarks / Tradenames |
|
|
185 |
|
|
|
- |
|
|
|
185 |
|
|
|
183 |
|
|
|
- |
|
|
|
183 |
|
Pioneer Germplasm |
|
|
975 |
|
|
|
- |
|
|
|
975 |
|
|
|
975 |
|
|
|
- |
|
|
|
975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,160 |
|
|
|
- |
|
|
$ |
1,160 |
|
|
$ |
1,158 |
|
|
|
- |
|
|
$ |
1,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,136 |
|
|
$ |
(1,509 |
) |
|
$ |
2,627 |
|
|
$ |
4,140 |
|
|
$ |
(1,456 |
) |
|
$ |
2,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
The aggregate amortization expense for definite-lived intangible assets was $57 and $172 for
the three-and nine-month periods ended September 30, 2006, respectively, and $57 and $171 for the
three-and nine-month periods ended September 30, 2005. The estimated aggregate pretax amortization
expense for 2006 and each of the next five years is approximately $230, $210, $190, $165, $130 and
$110.
Note 11. Commitments and Contingent Liabilities
Guarantees
Product Warranty Liability
The company warrants to the original purchaser of its products that it will, at its option refund,
repair or replace, without charge, such products if they fail due to a manufacturing defect. The
term of these warranties varies (30 days to 10 years) by product. The company has recourse
provisions for certain products that would enable recovery from third parties for amounts paid
under the warranties. The company accrues for product warranties when, based on available
information, it is probable that customers will make claims under warranties relating to products
that have been sold, and a reasonable estimate of the costs (based on historical claims experience
relative to sales) can be made.
The companys estimated product warranty liability as of September 30, 2006 is $16. In the first
quarter of 2006, the company increased its reserve for product warranty liability, primarily in the
Safety & Protection segment to reflect obligations related to certain product warranties. These
obligations were settled by the end of the third quarter. Set forth below is a reconciliation of
the companys estimated product warranty liability from December 31, 2005 through September 30,
2006:
|
|
|
|
|
Balance December 31, 2005 |
|
$ |
16 |
|
Settlements (cash and in-kind) |
|
|
(23 |
) |
Aggregate changes issued 2006 |
|
|
23 |
|
|
|
|
Balance September 30, 2006 |
|
$ |
16 |
|
|
|
|
Indemnifications
In connection with acquisitions and divestitures, the company has indemnified respective parties
against certain liabilities that may arise in connection with these transactions and business
activities prior to the completion of the transaction. The term of these indemnifications, which
typically pertain to environmental, tax and product liabilities, is generally indefinite. In
addition, the company indemnifies its duly elected or appointed directors and officers to the
fullest extent permitted by Delaware law against liabilities incurred as a result of their
activities for the company, such as adverse judgments relating to litigation matters. If the
indemnified party were to incur a liability or have a liability increase as a result of a
successful claim, pursuant to the terms of the indemnification, the company would be required to
reimburse the indemnified party. The maximum amount of potential future payments is generally
unlimited. The carrying amounts recorded for all indemnifications as of September 30, 2006 and
December 31, 2005 are $105 and $103, respectively. Although it is reasonably possible that future
payments may exceed amounts accrued, due to the nature of indemnified items, it is not possible to
make a reasonable estimate of the maximum potential loss or range of loss. No assets are held as
collateral and no specific recourse provisions exist.
In connection with the sale of the majority of the net assets of Textiles & Interiors (INVISTA),
the company indemnified the purchasers, subsidiaries of Koch Industries, Inc (Koch), against
certain liabilities primarily related to taxes, legal and environmental matters, and other
representations and warranties. The estimated fair value of these obligations of $70 is included
in the indemnification balance of $105 stated above. The fair value was based on managements best
estimate of the value expected to be required to issue the indemnifications in a stand alone, arms
length transaction with an unrelated party and, where appropriate, by the utilization of
probability-weighted discounted net cash flow models.
15
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Obligations for Equity Affiliates & Others
The company has directly guaranteed various debt obligations under agreements with third parties
related to equity affiliates, customers, suppliers and other unaffiliated companies. At September
30, 2006, the company had directly guaranteed $530 of such obligations, plus $259 relating to
guarantees of historical obligations for divested subsidiaries. This represents the maximum
potential amount of future (undiscounted) payments that the company could be required to make under
the guarantees.
In certain cases, the company has recourse to assets held as collateral, as well as personal
guarantees from customers and suppliers. Assuming liquidation, these assets are estimated to cover
approximately 33 percent of the $226 of guaranteed obligations of customers and suppliers. Set
forth below are the companys guaranteed obligations at September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short Term |
|
Long Term |
|
Total |
Obligations for customers, suppliers and other unaffiliated
companies1: |
|
|
|
|
|
|
|
|
|
|
|
|
Bank borrowings (terms up to 5 years) |
|
$ |
122 |
|
|
$ |
102 |
|
|
$ |
224 |
|
Revenue bonds (term 2 years) |
|
|
- |
|
|
|
2 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Obligations for equity affiliates2: |
|
|
|
|
|
|
|
|
|
|
|
|
Bank borrowings (terms up to 7 years) |
|
|
244 |
|
|
|
26 |
|
|
|
270 |
|
Leases on equipment and facilities (terms up to 4 years) |
|
|
- |
|
|
|
34 |
|
|
|
34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total obligations for customers, suppliers, other unaffiliated
companies and equity affiliates |
|
$ |
366 |
|
|
$ |
164 |
|
|
$ |
530 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Obligations for divested subsidiaries and affiliates3: |
|
|
|
|
|
|
|
|
|
|
|
|
Conoco (terms from 2-20 years) |
|
|
- |
|
|
|
156 |
|
|
|
156 |
|
Consolidation Coal Sales Company (term 4-5 years) |
|
|
- |
|
|
|
103 |
|
|
|
103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total obligations for divested subsidiaries and affiliates |
|
|
- |
|
|
|
259 |
|
|
|
259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
366 |
|
|
$ |
423 |
|
|
$ |
789 |
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Existing guarantees for customers and suppliers arose as part of contractual agreements. |
|
2 |
|
Existing guarantees for equity affiliates arose for liquidity needs in normal operations. |
|
3 |
|
The company has guaranteed certain obligations and liabilities related to divested subsidiaries, including Conoco and its
subsidiaries and affiliates, Consolidation Coal Sales Company, and INVISTA entities sold to Koch. The Restructuring,
Transfer and Separation Agreement between DuPont and Conoco requires Conoco to use its best efforts to have
Conoco, or any of its subsidiaries, substitute for DuPont. Conoco, Koch and Consolidation Coal Sales Company have
indemnified the company for any liabilities the company may incur pursuant to these guarantees. |
Residual Value Guarantees
As of September 30, 2006, the company had one synthetic lease program relating to short-lived
equipment. In connection with this synthetic lease program, the company had residual value
guarantees in the amount of $100 at September 30, 2006. The guarantee amounts are tied to the
unamortized lease values of the assets under synthetic lease and are due should the company decide
neither to renew these leases nor to exercise its purchase option. At September 30, 2006, the
company had no liabilities recorded for these obligations. Any residual value guarantee amounts
paid to the lessor may be recovered by the company from the sale of the assets to a third party.
16
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Litigation
BenlateÒ
In 1991, DuPont began receiving claims by growers that use of BenlateÒ 50 DF
fungicide had caused crop damage. DuPont has since been served with several hundred lawsuits, most
of which have been disposed of through trial, dismissal or settlement. The status of
BenlateÒ cases is indicated in the table below.
|
|
|
|
|
|
|
|
|
|
|
Status of Cases |
|
|
September 30, |
|
June 30, |
|
March 31, |
|
December 31, |
|
|
2006 |
|
2006 |
|
2006 |
|
2005 |
Filed |
|
|
|
|
|
|
|
|
Resolved |
|
2 |
|
|
|
1 |
|
30 |
Pending |
|
60 |
|
62 |
|
62 |
|
63 |
In March 2006, DuPont settled the only case pending in Australia alleging plant damage for
about 375 thousand dollars. Nine cases are pending in Florida state court, involving allegations
that BenlateÒ caused crop damage. Two of these cases, involving twenty-seven
Costa Rican fern growers, were tried during the second quarter of 2006 resulting in a $56 judgment
against DuPont. At trial, the plaintiffs sought damages in the range of $270 to $400. The
plaintiffs as well as DuPont have filed post trial motions and DuPont will appeal the verdict.
DuPont believes that the appeal will be resolved in its favor and, therefore, has not established a
reserve relating to the judgment.
Twenty-three of the pending cases seek to reopen settlements with the company by alleging that the
company committed fraud and misconduct, as well as violations of federal and state racketeering
laws. Plaintiffs are appealing the Florida federal courts dismissal of 16 of the reopener cases.
DuPont settled one of the two cases pending in Florida state court for 200 thousand dollars in
September 2006. In December 2005, the Ninth Circuit Court of Appeals reversed the Hawaii federal
courts dismissal of the five reopener cases before it. These five cases are scheduled for a
common issues trial in the first quarter 2007. The remaining case in Hawaii state court was
settled in part for $1.2. The remainder of this case was dismissed on DuPonts motion. Plaintiffs
have appealed.
In one of the three cases involving allegations that BenlateÒ caused birth defects to
children exposed in utero pending before it, the Delaware state court granted the companys motion
to dismiss due to insufficient scientific support for causation. Plaintiffs appealed and the
Delaware Supreme Court affirmed the dismissal in September 2006. The remaining two cases, which
were stayed pending the outcome of the appeal, may be activated. It is uncertain what impact, if
any, the Delaware Supreme Court decision will have on the two remaining cases.
Twenty-six cases involving damage to shrimp are pending against the company in state court in
Florida. The company contends that the injuries alleged are attributable to a virus, Taura
Syndrome Virus, and in no way involve BenlateÒ OD. One case was tried in late
2000 and another in early 2001. Both trials resulted in adverse judgments of approximately $14
each. The intermediate appellate court subsequently reversed the adverse verdicts and, in the
first quarter of 2005, judgments were entered in the companys favor in both cases. Plaintiffs
have filed a motion seeking sanctions for alleged discovery defaults in all of the cases, including
the two cases in which judgment has been entered for the company. Hearings regarding the motion
for sanctions have concluded and a ruling is expected in the fourth quarter of 2006.
The company does not believe that BenlateÒ caused the damages alleged in each of
these cases and denies the allegations of fraud and misconduct. The company continues to defend
itself in ongoing matters. As of September 30, 2006, the company has incurred costs and expenses
of approximately $2,000 associated with these matters. The company has recovered approximately
$275 of its costs and expenses through insurance and does not expect additional insurance
recoveries, if any, to be significant. While management recognizes that it is reasonably possible
that additional losses may be incurred, a range of such losses cannot be reasonably estimated at
this time. At September 30, 2006, no reserves exist for Benlate® litigation matters.
17
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
PFOA
U.S. Environmental Protection Agency (EPA) Complaints
In July and December 2004, the EPA filed administrative complaints against DuPont alleging that the
company failed to comply with the technical reporting requirements of the Toxic Substances Control
Act (TSCA) and the Resource Conservation and Recovery Act (RCRA) regarding PFOA, (collectively,
perfluorooctanoic acids and its salts, including the ammonium salt). The first complaint related
to information about PFOA for a period beginning in June 1981 through March 2001; the second
related to information about PFOA for a period beginning in late July 2004 to mid-October 2004. In
December 2005, the parties entered into a settlement agreement to resolve the original counts set
forth in the complaints and the additional counts raised by the EPA in 2005. As a result in 2005,
the company established reserves of $16.5 to fund its obligations under the settlement agreement.
The agreement requires the company to pay civil fines of $10.25 and fund two Supplemental
Environmental Projects at a total cost of $6.25. The company paid the civil fines of $10.25 in
January 2006 and expects that the projects will be completed, and the costs of $6.25 incurred, over
a three year period ending December 31, 2009.
Department of Justice: Grand Jury Subpoena
On May 17, 2005, DuPont was served with a grand jury subpoena from the U.S. District Court for the
District of Columbia. The subpoena, which was served by the Environmental Crimes Section of the
Environment and Natural Resources Division of the Department of Justice (DOJ), relates to PFOA,
ammonium perfluorooctanoate (APFO), C-8 and FC-143. The subpoena calls for the production of
documents previously produced to the EPA and other documents related to those chemicals. DuPont
has been and will continue to be fully responsive to the DOJ in this matter and has begun the
production of documents. It is expected that the collection, review and production of documents
will continue into 2007.
Class Actions: Drinking Water
In August 2001, a class action, captioned Leach v. DuPont, was filed in West Virginia state court
against DuPont and the Lubeck Public Service District. DuPont uses PFOA as a processing aid to
manufacture fluoropolymer resins and dispersions at various sites around the world including its
Washington Works plant in West Virginia. The complaint alleged that residents living near the
Washington Works facility had suffered, or may suffer, deleterious health effects from exposure to
PFOA in drinking water. The relief sought included damages for medical monitoring, diminution of
property values, and punitive damages plus injunctive relief to stop releases of PFOA. DuPont and
attorneys for the class reached a settlement agreement in 2004 and as a result, the company
established reserves of $108 in 2004. The agreement was approved by the Wood County Circuit Court
on February 28, 2005 after a fairness hearing. The settlement binds a class of approximately
80,000 residents. As defined by the court, the class includes those individuals who have consumed,
for at least one year, water containing 0.05 parts per billion (ppb) or greater of PFOA from any of
six designated public water sources or from sole source private wells.
In July 2005, the company paid the plaintiffs attorneys fees and expenses of $23 and made a
payment of $70, which class counsel has designated to fund a community health project. The company
also is funding a health study by an independent science panel of experts in the communities
exposed to PFOA to evaluate available scientific evidence on whether any probable link exists
between exposure to PFOA and human disease. The independent science panel health study is estimated
to cost $15, of which $5 was originally placed in an interest-bearing escrow account. The expected
timeframe to complete the study is four to six years. In addition, the company is providing
state-of-the art water treatment systems designed to reduce the level of PFOA in water to six area
water districts until the science panel completes its work. The estimated cost of constructing,
operating and maintaining these systems has been refined and therefore, increased from $18 to
$19.3, of which $10 was originally placed in an interest-bearing escrow account. As a result, in
the third quarter 2006, the company increased its reserves relating to this matter by $1.3
reflecting the refined cost estimates for the water treatment systems. Also, the company is funding
a bottled water program (estimated to cost about $3) for residents in one water district on an
interim basis until the installation of the water treatment systems. As a result of this reserve
addition,
18
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
payments and activities undertaken pursuant to the settlement agreement during the period, the
reserve balance at September 30, 2006 was $27, including $8 in interest bearing escrow accounts.
The settlement resulted in the dismissal of all claims asserted in the lawsuit except for personal
injury claims. If the independent science panel concludes that no probable link exists between
exposure to PFOA and any diseases, then the settlement would also resolve personal injury claims.
If it concludes that a probable link does exist between exposure to PFOA and any diseases, then
DuPont would also fund up to $235 for a medical monitoring program to pay for such medical testing.
In this event, plaintiffs would retain their right to pursue personal injury claims. All other
claims in the lawsuit would remain dismissed by the settlement. DuPont believes that it is remote
that the panel will find a probable link. Therefore, at September 30, 2006, the company had not
established any reserves related to this matter. However, there can be no assurance as to what the
independent science panel will conclude.
The Little Hocking Water Association was one of the six area water districts for whom DuPont was to
offer to design and construct a state of the art water treatment system under the settlement.
Little Hocking opted out of the settlement and in May 2006 sued DuPont in Ohio state court claiming
that perfluorinated compounds (including PFOA) allegedly released from the Washington Works plant
contaminated its well fields and underlying aquifer. Little Hocking sought a variety of relief
including compensatory and punitive damages, and an injunction requiring the company to provide a
new pristine well field and the infrastructure to deliver it. In September 2006, Little Hocking
voluntarily dismissed its lawsuit without prejudice.
In the second quarter of 2006, three purported class actions were filed alleging that drinking
water had been contaminated by PFOA in excess of 0.05 ppb due to alleged releases from certain
DuPont plants. One of these cases was filed in West Virginia state court on behalf of customers of
the Parkersburg City Water District, but was removed on DuPonts motion to the U.S. District Court
for the Southern District of West Virginia. The other two purported class actions were filed in New
Jersey. One was filed in federal court on behalf of individuals who allegedly drank water
contaminated by releases from DuPonts Chambers Works plant in Deepwater, New Jersey. The second
was filed in state court on behalf of customers serviced primarily by the Pennsville Township Water
Department and was removed to New Jersey federal district court on DuPonts motion.
The company intends to defend itself vigorously against these lawsuits alleging contamination of
drinking water sources. While DuPont believes that it is reasonably possible that it will incur
losses related to PFOA, a range of such loss, if any, cannot be reasonably estimated at this time.
Consumer Products Class Actions
|
|
|
|
|
|
|
|
|
|
|
Status of Cases |
|
|
September 30, |
|
June 30, |
|
March 31, |
|
December 31, |
|
|
2006 |
|
2006 |
|
2006 |
|
2005 |
Filed |
|
1 |
|
5 |
|
1 |
|
15 |
Resolved |
|
|
|
|
|
|
|
|
Pending |
|
22 |
|
21 |
|
16 |
|
15 |
As of September 30, 2006, 22 intrastate class actions have been filed on behalf of consumers
that have purchased cookware with Teflon® non-stick coating in federal district courts
against DuPont. The actions were filed on behalf of consumers in Colorado, Connecticut, Delaware,
the District of Columbia, Florida, Illinois, Indiana, Iowa, Kentucky, Massachusetts, Michigan,
Missouri, New Jersey, New Mexico, New York, Ohio, Pennsylvania, South Carolina, Texas and West
Virginia and two were filed in California. By order of the Judicial Panel on Multidistrict
Litigation, all of these actions have been combined for coordinated and consolidated pretrial
proceedings in federal district court for the Southern District of Iowa. The proceedings in this
court will include the central question of whether these cases can proceed as class actions. A
ruling on this issue is not expected before 2007.
19
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
The actions allege that DuPont violated state laws by engaging in deceptive and unfair trade
practices by failing to disclose to consumers that products containing Teflon® were or
are potentially harmful to consumers and that DuPont has liability based on state law theories of
negligence and strict liability. The actions allege that Teflon® contained or released
harmful and dangerous substances, including a chemical (PFOA) alleged to have been determined to be
likely to cause cancer in humans. The actions seek unspecified monetary damages for consumers
who purchased cooking products containing Teflon®, as well as the creation of funds for
medical monitoring and independent scientific research, attorneys fees and other relief.
In December 2005, a motion was filed by a single named plaintiff in the Superior Court for the
Province of Quebec, Canada seeking authorization to institute a class action on behalf of all
Quebec consumers who have purchased or used kitchen items, household appliances or food-packaging
containing Teflon® or Zonyl® non-stick coatings. Damages are not quantified,
but are alleged to include the cost of replacement products as well as one hundred dollars per
class member as exemplary damages. In June 2006, plaintiffs filed an additional motion seeking
authorization to expand the purported class to include all Canadian consumers of these products,
not just Quebec residents. The Court is not expected to rule on this latest motion until late 2006.
The company believes that the 22 class actions and the motion filed in Quebec are without merit
and, therefore, believes it is remote that it will incur losses related to these actions. At
September 30, 2006, the company had not established any reserves related to these matters.
Elastomers Antitrust Matters
Investigations of the U.S., European Union and Canadian synthetic rubber markets for possible
antitrust violations are ongoing. These investigations included DuPont Dow Elastomers, LLC, (DDE)
as a result of its participation in the polychloroprene (PCP) and ethylene propylene diene monomer
(EPDM) markets. DDE was a joint venture between The Dow Chemical Company (Dow) and DuPont. DDE and
DuPont were named in related civil litigation.
In April of 2004, DuPont and Dow entered into a series of agreements under which DuPont obtained
complete control over directing DDEs response to these investigations and the related litigation,
and DuPont agreed to a disproportionate share of the ventures liabilities and costs related to
these matters. Consequently, DuPont bears any potential liabilities and costs up to the initial
$150. Dow is obligated to indemnify DuPont for up to $72.5 by paying 15 to 30 percent toward
liabilities and costs in excess of $150. On June 30, 2005, DDE became a wholly owned subsidiary of
DuPont and was renamed DuPont Performance Elastomers LLC (DPE).
DDE resolved all criminal antitrust allegations against it related to PCP in the U.S. through a
plea agreement with the DOJ in January 2005 which was approved by the court on March 29, 2005. The
agreement requires the subsidiary to pay a fine of $84 which, at its election, may be paid in six
equal, annual installments. The annual installment payments for 2005 and 2006 have been made. The
agreement also requires the subsidiary to provide ongoing cooperation with the DOJs investigation.
DDE responded to investigations by European Union and Canadian antitrust authorities and DPE
continues to cooperate with the authorities.
In November of 2004, the court approved the settlement reached by DDE and attorneys for the class,
of federal antitrust litigation related to PCP for $42, including attorneys fees and costs. DDE
also reached a settlement with attorneys for the class, of federal antitrust litigation related to
EPDM for $24.6, including attorneys fees and costs. The court approved the EPDM settlement in May
2005. During the second quarter of 2006, the court-appointed fund administrators returned a portion
of the class settlement paid in connection with the PCP class action related to individual
claimants that opted out of the class. Including the PCP and EPDM class settlements, net of the PCP
class action funds returned to the company, related to civil lawsuits and claims alleging antitrust
violations in certain synthetic rubber markets, the company has paid $106 through September 30,
2006. As of September 30, 2006 there are no pending civil lawsuits or claims.
20
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
As a result of its April 2004 agreements with Dow, DuPont established reserves in 2004 of $268, of
which $18 will be reimbursed by Dow to reflect its share of anticipated losses. At September 30,
2006, the balance of the reserves is $126, which reflects net adjustments made for claimants who
opted out of the PCP settlement during the second quarter 2006, and includes $56 for the remaining
four installment payments to be made under the plea agreement with the DOJ. Given the uncertainties
inherent in predicting the outcome of these matters and the likelihood of additional future claims
it is reasonably possible that actual losses may exceed the amount accrued. However, a range of
such losses cannot be reasonably estimated at this time.
General
The company is subject to various lawsuits and claims arising out of the normal course of its
business. These lawsuits and claims include actions based on alleged exposures to products,
intellectual property and environmental matters, and contract and antitrust claims. Management has
noted a nationwide trend in purported class actions against chemical manufacturers generally
seeking relief such as medical monitoring, property damages, off-site remediation and punitive
damages arising from alleged environmental torts without claiming present personal injuries. Such
cases may allege contamination from unregulated substances or remediated sites. For example, in
September 2006 a West Virginia state court certified a class action against DuPont seeking damages
similar to those listed above allegedly related to a closed zinc smelter. The smelter was owned and
operated by at least three companies between 1910 and 2001, including DuPont between 1928 and 1950.
DuPont performed remedial measures at the request of the EPA in the late 1990s and in 2001
repurchased the site to facilitate and complete the remediation. The company contests the merits
of this case and plans to defend itself vigorously against this and similar cases, if any, in the
future. Although it is not possible to predict the outcome of these various lawsuits and claims,
management does not anticipate they will have a material adverse effect on the companys
consolidated financial position or liquidity. However, the ultimate liabilities may be significant
to results of operations in the period recognized. The company accrues for contingencies when the
information available indicates that it is probable that a liability has been incurred and the
amount of the liability can be reasonably estimated.
Environmental
The company is also subject to contingencies pursuant to environmental laws and regulations that in
the future may require the company to take further action to correct the effects on the environment
of prior disposal practices or releases of chemical or petroleum substances by the company or other
parties. Additional information relating to environmental remediation activity is contained in
Notes 1 and 24 to the companys Consolidated Financial Statements included in the companys Annual
Report on Form 10-K for the year ended December 31, 2005. At September 30, 2006, the companys
Consolidated Balance Sheet includes a liability of $347 relating to these matters and, in
managements opinion, is appropriate based on existing facts and circumstances. Considerable
uncertainty exists with respect to these costs and, under adverse changes in circumstances,
potential liability may range up to two to three times the amount accrued at September 30, 2006.
21
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 12. Comprehensive Income (Loss)
The following sets forth the companys total comprehensive income (loss) for the periods shown:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
485 |
|
|
$ |
(82 |
) |
|
$ |
2,277 |
|
|
$ |
1,900 |
|
Cumulative translation adjustment |
|
|
15 |
|
|
|
(9 |
) |
|
|
40 |
|
|
|
(105 |
) |
Net revaluation and clearance of cash flow
hedges to earnings |
|
|
(2 |
) |
|
|
(7 |
) |
|
|
(3 |
) |
|
|
(9 |
) |
Minimum pension liability |
|
|
16 |
|
|
|
7 |
|
|
|
16 |
|
|
|
7 |
|
Net unrealized gains (losses) on available
for sale securities |
|
|
- |
|
|
|
2 |
|
|
|
6 |
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
514 |
|
|
$ |
(89 |
) |
|
$ |
2,336 |
|
|
$ |
1,782 |
|
|
|
|
|
|
|
|
|
|
Note 13. Derivatives and Other Hedging Instruments
The companys objectives and strategies for holding derivative instruments are included in Note 29
to the companys Consolidated Financial Statements included in the companys Annual Report on Form
10-K for the year ended December 31, 2005. During the nine-month period ended September 30, 2006,
hedge ineffectiveness of $1 was reported in earnings. There were no hedge gains or losses excluded
from the assessment of hedge effectiveness or reclassifications to earnings for forecasted
transactions that did not occur related to cash flow hedges.
The following table summarizes the effect of cash flow hedges on accumulated other comprehensive
income (loss) for the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
|
September 30, 2006 |
|
September 30, 2006 |
|
|
Pretax |
|
Tax |
|
After-Tax |
|
Pretax |
|
Tax |
|
After-Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance |
|
$ |
1 |
|
|
$ |
- |
|
|
$ |
1 |
|
|
$ |
3 |
|
|
$ |
(1 |
) |
|
$ |
2 |
|
Additions and revaluations of
derivatives designated as cash
flow hedges |
|
|
(5 |
) |
|
|
2 |
|
|
|
(3 |
) |
|
|
(11 |
) |
|
|
3 |
|
|
|
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clearance of hedge results to
earnings |
|
|
2 |
|
|
|
(1 |
) |
|
|
1 |
|
|
|
6 |
|
|
|
(1 |
) |
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance |
|
$ |
(2 |
) |
|
$ |
1 |
|
|
$ |
(1 |
) |
|
$ |
(2 |
) |
|
$ |
1 |
|
|
$ |
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts expected to be
reclassified into earnings over
the next twelve months |
|
$ |
(3 |
) |
|
$ |
1 |
|
|
$ |
(2 |
) |
|
$ |
(3 |
) |
|
$ |
1 |
|
|
$ |
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
22
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 14. Employee Benefits
The following sets forth the components of the companys net periodic pension benefit cost:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
96 |
|
|
$ |
89 |
|
|
$ |
294 |
|
|
$ |
270 |
|
Interest cost |
|
|
298 |
|
|
|
290 |
|
|
|
888 |
|
|
|
872 |
|
Expected return on plan assets |
|
|
(413 |
) |
|
|
(355 |
) |
|
|
(1,224 |
) |
|
|
(1,047 |
) |
Amortization of transition asset |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(1 |
) |
Amortization of unrecognized loss |
|
|
57 |
|
|
|
73 |
|
|
|
190 |
|
|
|
228 |
|
Amortization of prior service cost |
|
|
8 |
|
|
|
10 |
|
|
|
29 |
|
|
|
28 |
|
Curtailment/settlement loss |
|
|
- |
|
|
|
- |
|
|
|
3 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
45 |
|
|
$ |
106 |
|
|
$ |
179 |
|
|
$ |
361 |
|
|
|
|
|
|
|
|
|
|
The company disclosed in its Consolidated Financial Statements for the year ended December 31,
2005, that it expected to contribute approximately $280 to its pension plans, other than to the
principal U.S. pension plan in 2006. As of September 30, 2006, contributions of $226 have been
made to these pension plans and the company anticipates additional contributions of approximately
$43 during the remainder of 2006.
In August 2006, the company announced major changes to its principal U.S. pension plan and savings
plan. Employees hired after December 31, 2006 will participate in the enhanced savings plan, but
not in the pension plan. Active employees on the rolls as of December 31, 2006 will participate in
the enhanced savings plan effective January 1, 2008, and will continue to accrue benefits in the
pension plan, but at a reduced rate. In addition, company paid postretirement survivor benefits
will not continue to grow after December 31, 2007.
As a result of the announced plan amendment, the company is required to remeasure its pension
expense for the remainder of 2006, reflecting plan assets and benefit obligations as of the
remeasurement date. Better than expected return on plan assets and a higher discount rate of 6.0
percent will lower pretax pension expense over the remainder of the
year by $72. Twenty-five percent of this amount was recognized in the third quarter of 2006.
The following sets forth the components of the companys net periodic cost for other postretirement
benefits:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
Service cost |
|
$ |
9 |
|
|
$ |
8 |
|
|
$ |
25 |
|
|
$ |
25 |
|
Interest cost |
|
|
53 |
|
|
|
64 |
|
|
|
161 |
|
|
|
196 |
|
Amortization of unrecognized loss |
|
|
11 |
|
|
|
22 |
|
|
|
34 |
|
|
|
59 |
|
Amortization of prior service cost |
|
|
(39 |
) |
|
|
(40 |
) |
|
|
(117 |
) |
|
|
(117 |
) |
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
34 |
|
|
$ |
54 |
|
|
$ |
103 |
|
|
$ |
163 |
|
|
|
|
|
|
|
|
|
|
The company disclosed in its Consolidated Financial Statements for the year ended December 31,
2005, that it expected to make payments of approximately $350 to its other postretirement benefit
plans in 2006. Through September 30, 2006, the company has made benefit payments of $257 related
to its postretirement benefit plans and anticipates additional payments of approximately $86 during
the remainder of 2006.
23
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
Note 15. Segment Information
Segment sales include transfers and a pro rata share of equity affiliates sales. Segment pretax
operating income (PTOI) is defined as operating income before income taxes, minority interests,
exchange gains (losses), corporate expenses and interest.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings & |
|
Electronic & |
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Agriculture |
|
Color |
|
Communication |
|
Performance |
|
Pharma- |
|
Safety & |
|
|
|
|
September 30, |
|
& Nutrition |
|
Technologies |
|
Technologies |
|
Materials |
|
ceuticals |
|
Protection |
|
Other |
|
Total1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment sales |
|
$ |
967 |
|
|
$ |
1,617 |
|
|
$ |
955 |
|
|
$ |
1,739 |
|
|
$ |
- |
|
|
$ |
1,405 |
|
|
$ |
16 |
|
|
$ |
6,699 |
|
Less transfers |
|
|
- |
|
|
|
(13 |
) |
|
|
(25 |
) |
|
|
(14 |
) |
|
|
- |
|
|
|
(19 |
) |
|
|
- |
|
|
|
(71 |
) |
Less equity affiliates
sales |
|
|
(21 |
) |
|
|
(5 |
) |
|
|
(63 |
) |
|
|
(210 |
) |
|
|
- |
|
|
|
(20 |
) |
|
|
- |
|
|
|
(319 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
946 |
|
|
|
1,599 |
|
|
|
867 |
|
|
|
1,515 |
|
|
|
- |
|
|
|
1,366 |
|
|
|
16 |
|
|
|
6,309 |
|
Pretax operating
income (loss) |
|
|
(158 |
) |
|
|
276 |
2 |
|
|
135 |
|
|
|
172 |
|
|
|
210 |
|
|
|
292 |
2 |
|
|
(27 |
) |
|
|
900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment sales |
|
$ |
997 |
|
|
$ |
1,501 |
|
|
$ |
919 |
|
|
$ |
1,539 |
|
|
$ |
- |
|
|
$ |
1,268 |
|
|
$ |
14 |
|
|
$ |
6,238 |
|
Less transfers |
|
|
- |
|
|
|
(12 |
) |
|
|
(24 |
) |
|
|
(12 |
) |
|
|
- |
|
|
|
(20 |
) |
|
|
- |
|
|
|
(68 |
) |
Less equity affiliates
sales |
|
|
(24 |
) |
|
|
(4 |
) |
|
|
(58 |
) |
|
|
(193 |
) |
|
|
- |
|
|
|
(21 |
) |
|
|
- |
|
|
|
(300 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
973 |
|
|
|
1,485 |
|
|
|
837 |
|
|
|
1,334 |
|
|
|
- |
|
|
|
1,227 |
|
|
|
14 |
|
|
|
5,870 |
|
Pretax operating
income (loss) |
|
|
(134 |
) |
|
|
26 |
3 |
|
|
145 |
|
|
|
68 |
3 |
|
|
197 |
|
|
|
256 |
3 |
|
|
(13 |
) 5 |
|
|
545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coatings & |
|
Electronic & |
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
Agriculture & |
|
Color |
|
Communication |
|
Performance |
|
Pharma- |
|
Safety & |
|
|
|
|
September 30, |
|
Nutrition |
|
Technologies |
|
Technologies |
|
Materials
6 |
|
ceuticals |
|
Protection |
|
Other |
|
Total1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment sales |
|
$ |
5,234 |
|
|
$ |
4,729 |
|
|
$ |
2,903 |
|
|
$ |
5,189 |
|
|
$ |
- |
|
|
$ |
4,223 |
|
|
$ |
45 |
|
|
$ |
22,323 |
|
Less transfers |
|
|
- |
|
|
|
(35 |
) |
|
|
(86 |
) |
|
|
(54 |
) |
|
|
- |
|
|
|
(63 |
) |
|
|
- |
|
|
|
(238 |
) |
Less equity affiliates
sales |
|
|
(61 |
) |
|
|
(14 |
) |
|
|
(184 |
) |
|
|
(616 |
) |
|
|
- |
|
|
|
(65 |
) |
|
|
- |
|
|
|
(940 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
5,173 |
|
|
|
4,680 |
|
|
|
2,633 |
|
|
|
4,519 |
|
|
|
- |
|
|
|
4,095 |
|
|
|
45 |
|
|
|
21,145 |
|
Pretax operating
income (loss) |
|
|
858 |
|
|
|
513 |
2,7 |
|
|
467 |
|
|
|
502 |
|
|
|
579 |
|
|
|
871 |
2 |
|
|
(83 |
) |
|
|
3,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment sales |
|
$ |
5,455 |
|
|
$ |
4,606 |
|
|
$ |
2,777 |
|
|
$ |
5,160 |
|
|
$ |
- |
|
|
$ |
3,938 |
|
|
$ |
39 |
|
|
$ |
21,975 |
|
Less transfers |
|
|
- |
|
|
|
(39 |
) |
|
|
(75 |
) |
|
|
(61 |
) |
|
|
- |
|
|
|
(53 |
) |
|
|
- |
|
|
|
(228 |
) |
Less equity affiliates
sales |
|
|
(59 |
) |
|
|
(23 |
) |
|
|
(198 |
) |
|
|
(592 |
) |
|
|
- |
|
|
|
(63 |
) |
|
|
- |
|
|
|
(935 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
|
5,396 |
|
|
|
4,544 |
|
|
|
2,504 |
|
|
|
4,507 |
|
|
|
- |
|
|
|
3,822 |
|
|
|
39 |
|
|
|
20,812 |
|
Pretax operating
income (loss) |
|
|
1,134 |
|
|
|
375 |
3 |
|
|
472 |
8 |
|
|
469 |
3,4 |
|
|
548 |
|
|
|
770 |
3 |
|
|
(27 |
) 5 |
|
|
3,741 |
|
24
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in millions, except per share)
|
|
|
1 |
|
A reconciliation of the pretax operating income totals
reported for the operating segments to the applicable line item on the Consolidated Financial Statements is as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine months Ended |
|
|
September 30, |
|
September 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment PTOI |
|
$ |
900 |
|
|
$ |
545 |
|
|
$ |
3,707 |
|
|
$ |
3,741 |
|
Net exchange gains (losses), including affiliates |
|
|
(3 |
) |
|
|
71 |
|
|
|
5 |
|
|
|
365 |
|
Corporate expenses and net interest |
|
|
(261 |
) |
|
|
(266 |
) |
|
|
(771 |
) |
|
|
(703 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes and minority interests |
|
$ |
636 |
|
|
$ |
350 |
|
|
$ |
2,941 |
|
|
$ |
3,403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Includes a benefit of $50 resulting from initial insurance recoveries relating to the damage suffered from hurricane Katrina in 2005 in the
following segments: Coatings & Color Technologies-$43 and Safety & Protection-$7. See Note 4 for additional information. |
|
3 |
|
Includes a $146 charge for damaged facilities, inventory write-offs, clean-up costs, and other costs related to the hurricanes, in the following
segments: Coatings & Color Technologies-$113; Performance Materials-$11; and Safety & Protection-$22. See Note 4 for additional information. |
|
4 |
|
Includes a gain of $23 from the disposition of certain assets of DDE to Dow and a charge of $34 related to the shutdown of an elastomers
manufacturing facility in the U.S. |
|
5 |
|
Includes a gain of $20 in the third quarter of 2005 and a
gain of $59 in the nine months ended September 30, 2005 relating to the ongoing separation of Textiles &
Interiors, partly offset by other separation costs. See Note 6 for additional information. |
|
6 |
|
Includes the following results from Engage®, Nordel®, and Tyrin® businesses transferred to Dow on June 30, 2005. |
|
|
|
|
|
|
|
Nine Months Ended |
|
|
September 30, |
|
|
2005 |
Net Sales |
|
$ |
386 |
|
Pretax operating income |
|
|
47 |
|
|
|
|
7 |
|
Includes a $135 restructuring charge, which is discussed in more detail in Note 5. |
|
8 |
|
Includes a gain of $48 resulting from the sale of the companys equity interest in DuPont Photomasks Inc. |
25
Item 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
Cautionary Statements About Forward-Looking Statements
This report contains forward-looking statements which may be identified by their use of words like
plans, expects, will, anticipates, intends, projects, estimates or other words of
similar meaning. All statements that address expectations or projections about the future,
including statements about the companys strategy for growth, product development, market position,
expenditures and financial results, are forward-looking statements.
Forward-looking statements are based on certain assumptions and expectations of future events.
The company cannot guarantee that these assumptions and expectations are accurate or will be
realized. For some of the important factors that could cause the companys actual results to differ
materially from those projected in any such forward-looking statements see the Risk Factors
discussion set forth under Part II, Item 1A beginning on page 39.
Results of Operations
Overview
The company grew revenue in the third quarter, as its pricing momentum continued for the
11th consecutive quarter. Sales volumes recovered from the impact of last years
hurricanes. Pretax operating margin also expanded on the strength of higher prices and lower fixed
costs. The companys execution plans in all businesses include specific pricing actions and cost
productivity improvements. The growth strategies successfully generated top and bottom line growth
against a backdrop of higher raw material costs, and lower North American auto builds and United
States (U.S.) residential construction.
Net Sales
Consolidated net sales for the third quarter were $6.3 billion versus $5.9 billion in the prior
year, up 7 percent with a 3 percent increase in local selling prices, a 1 percent favorable
currency exchange and a 3 percent increase in volume. The company estimates that half of the
volume increase is due to recovered sales lost during the 2005 hurricane related business
interruptions. The company experienced double digit sales growth in Europe and Asia Pacific
regions and rising selling prices worldwide. Particularly robust sales were recorded for titanium
dioxide (TiO2), engineering and packaging polymers and industrial chemical and
electronic materials.
The table below shows net sales by region and variance analysis versus the prior year:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
September 30, 2006 |
|
Percent Change Versus 2005 |
|
|
2006 |
|
Percent |
|
|
|
|
|
|
|
|
Net Sales |
|
Change |
|
Local |
|
Currency |
|
|
|
|
($ Billions) |
|
vs. 2005 |
|
Price |
|
Effect |
|
Volume |
Worldwide |
|
$ |
6.3 |
|
|
|
7 |
|
|
|
3 |
|
|
|
1 |
|
|
|
3 |
|
U.S. |
|
|
2.5 |
|
|
|
4 |
|
|
|
3 |
|
|
|
- |
|
|
|
1 |
|
Europe |
|
|
1.7 |
|
|
|
11 |
|
|
|
3 |
|
|
|
4 |
|
|
|
4 |
|
Asia Pacific |
|
|
1.2 |
|
|
|
12 |
|
|
|
2 |
|
|
|
(1 |
) |
|
|
11 |
|
Canada & Latin America |
|
|
0.9 |
|
|
|
4 |
|
|
|
3 |
|
|
|
2 |
|
|
|
(1 |
) |
26
For the nine months ended September 30, 2006, consolidated net sales were $21.1 billion versus
$20.8 billion in the prior year, up 2 percent. Excluding prior-year sales of elastomers businesses
transferred to
The Dow Chemical Company (Dow), sales increased 4 percent, reflecting 3 percent higher local
selling prices, and 2 percent higher volume partly offset by a 1 percent negative currency impact.
Local selling prices were up in all regions and volumes grew in all regions except the U.S. Volume
growth was most significant in the Asia Pacific region, primarily driven by increased sales of
engineering polymers, electronic materials, aramids, and nonwovens. Lower volume in the U.S. is
principally due to lower sales of products for production agriculture.
The table below shows net sales by region versus the prior year and variance analysis after
considering portfolio changes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended |
|
Percent Change Versus 2005 After Adjusting for |
|
|
September 30, 2006 |
|
Portfolio Changes * |
|
|
2006 |
|
Percent |
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales |
|
Change |
|
|
|
|
|
Local |
|
Currency |
|
|
|
|
($ Billions) |
|
vs. 2005 |
|
Total |
|
Price |
|
Effect |
|
Volume |
Worldwide |
|
$ |
21.1 |
|
|
|
2 |
|
|
|
4 |
|
|
|
3 |
|
|
|
(1 |
) |
|
|
2 |
|
U.S. |
|
|
9.0 |
|
|
|
- |
|
|
|
2 |
|
|
|
3 |
|
|
|
- |
|
|
|
(1 |
) |
Europe |
|
|
6.0 |
|
|
|
(1 |
) |
|
|
0 |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
1 |
|
Asia Pacific |
|
|
3.5 |
|
|
|
5 |
|
|
|
8 |
|
|
|
3 |
|
|
|
(3 |
) |
|
|
8 |
|
Canada & Latin |
|
|
2.6 |
|
|
|
9 |
|
|
|
9 |
|
|
|
3 |
|
|
|
3 |
|
|
|
3 |
|
|
|
|
* |
|
Excludes sales of $386 million for 2005 year-to-date attributable to the elastomers businesses that were transferred to
Dow on June 30, 2005. |
Other Income, Net
Third quarter 2006 Other income, net totaled $336 million versus $438 million in the prior year,
primarily due to lower pretax exchange gains in connection with the companys policy of hedging its
foreign currency denominated monetary assets and liabilities. Third quarter pretax exchange results
were a loss of $1 million in 2006 and a gain of $68 million in 2005. These results were largely
offset by associated tax expense. Interest income, net of miscellaneous interest expense is also
lower due to lower invested cash.
For the nine months ended September 30, 2006, Other income, net was $1,002 million as compared to
$1,444 million last year. The changes year over year are primarily the result of the currency
hedging program activities described above. In addition, there was a decrease in net
miscellaneous interest income due to lower invested cash.
Additional information related to the companys Other income, net is included in Note 3 to the
interim Consolidated Financial Statements.
Cost of Goods Sold and Other Operating Charges (COGS)
COGS for the third quarter 2006 was $4.8 billion and 75 percent of Sales versus $4.7 billion and 80
percent of Sales in the prior year. The increase in COGS reflects higher volume and higher raw
material costs. 2006 COGS includes a $50 million initial insurance recovery related to hurricane
damage sustained in 2005. Third quarter 2005 COGS included a charge of $146 million related to
hurricane damage experienced at plant sites in the U.S.
COGS for the nine months ended September 30, 2006 was $15.3 billion, up 2 percent versus prior
year, reflecting higher raw material costs. COGS in both years were 72 percent of sales on a
year-to-date basis. Included in COGS for 2006 is the previously discussed insurance recovery, a
charge of $135 million in the first quarter 2006 (described below) within the Coatings & Color
Technologies segment and $20 million primarily for accelerated depreciation associated with actions under the
Coatings & Color Technologies business transformation plan. These factors were partly offset by the
absence in 2006 of DDE businesses transferred to Dow. 2005 COGS included a $146 million hurricane
charge.
27
During the first quarter 2006, a business transformation plan was instituted within the Coatings &
Color Technologies segment in order to better serve the companys customers and improve
profitability. The
plan includes the elimination of 1,700 positions and encompasses redeployment of employees in
excess positions to the extent possible. Restructuring charges resulting from the plan include $123
million related to severance costs for approximately 1,300 employees involved in manufacturing,
marketing, administrative and technical activities who are expected to be off the rolls by fourth
quarter 2007. In connection with the plan, a $12 million charge was also recorded during the first
quarter 2006 related to exit costs of non-strategic assets. The business transformation plan
includes the closing of certain manufacturing and technical facilities which will result in
additional charges of about $50 million through the second quarter 2007, principally associated
with accelerated depreciation, dismantlement and removal of assets, certain contract terminations
and other related costs. The company may incur additional charges related to this plan; however,
management does not expect such charges to be material.
There were no changes in estimates related to reserves established for this plan during the second
and third quarter 2006. As of September 30, 2006, approximately 475 employees were separated from
the company and approximately 300 were redeployed. Cash payments, net of exchange impact on the
reserve, related to these separations were $19 million. The majority of the remaining payments are
expected to be completed by the end of 2007. The cost reduction initiatives related to these
charges are expected to deliver to the company about $135 million in annualized savings when
completed. Approximately 35 percent of the savings are expected to be realized in 2006, with an
additional 50 percent in 2007 and the remainder in 2008.
Information related to the companys prior year corporate restructuring activities is included in
Note 5 to the interim Consolidated Financial Statements.
Selling, General and Administrative Expenses (SG&A)
SG&A totaled $756 million for the quarter versus $751 million in the prior year. Year-to-date SG&A
totaled $2,400 million versus $2,424 million in 2005. As a percent of Net sales, for the quarter
and year-to-date 2006 periods, SG&A was 1 percent lower than the comparable periods in the prior
year, reflecting the companys execution of cost controls while continuing to spend for growth
initiatives.
Research and Development Expense (R&D)
R&D totaled $320 million in the third quarter of 2006 as compared to $324 million last year.
Spending for R&D was 5 percent of sales in the third quarter of 2006 and 6 percent of sales for the
comparable period in 2005. Spending as a percent of sales was lower in 2006 than 2005 as a result
of the hurricane disruption which lowered sales in that period. For the nine months ended September
30, 2006, R&D was $961 million versus $976 million last year. R&D spending was constant at about 5
percent of sales for the first nine months of both years, consistent with the companys commitment
of sustainable growth. During the first nine months of 2006, the company introduced over 900 new
products and product applications in its program to deliver market relevant offerings.
Interest Expense
Interest expense totaled $114 million in the third quarter of 2006, compared to $140 million last
year. Average interest rates were virtually unchanged year over year but average debt balances
were reduced over $2 billion from last years third quarter. For the first nine months of 2006,
interest expense was $347 million versus $364 million in 2005 primarily reflecting lower average
debt for the period.
Separation Activities - Textiles & Interiors
In January 2006, the company completed the sale of its interest in the last equity affiliate to its
equity partner, completing the separation of Textiles & Interiors. There was no charge or gain
incurred as a result of this sale.
In the third quarter of 2005, the company recorded a gain of $20 million related to the sale of its
investment in an equity affiliate to subsidiaries of Koch Industries, Inc. (Koch), and other
credits of
28
$3 million related to the ongoing separation of Textiles &Interiors. Year-to-date 2005
also includes a net gain of $39 million primarily related to the transfer of two previously delayed
equity affiliates to Koch and the sale of an equity affiliate to its equity partner.
Provision for Income Taxes
The companys effective tax rates for third quarter and year-to-date 2006 were 23.9 percent and
22.5 percent, respectively, as compared to 124.3 percent and 42.9 percent for the comparable
prior-year periods. The lower effective tax rates for 2006 versus 2005 are principally related to
the $320 million tax expense for the repatriation under the American Jobs Creation Act of 2004
(AJCA) in third quarter 2005 and the companys policy of hedging the foreign currency-denominated
monetary assets and liabilities of its operations. See Note 7 to the interim Consolidated
Financial Statements for additional information.
Minority Interests in Earnings (Losses) of Consolidated Subsidiaries
Minority interests in earnings (losses) of consolidated subsidiaries were $(1) million and $2
million for the three and nine months ended September 30, 2006 as compared with $(3) million and
$42 million in the same periods in 2005. Charges incurred during 2005 largely reflect the first
half of the year earnings of DDE, a 50/50 joint venture which was consolidated as a variable
interest entity. On June 30, 2005, DDE became a wholly owned subsidiary of DuPont and was renamed
DuPont Performance Elastomers LLC (DPE).
Net Income
Net income for the third quarter 2006 was $485 million, including a $33 million after-tax benefit
from initial insurance recoveries for prior-year hurricane damage. Net income for the third
quarter 2005 was a loss of $82 million, largely due to an AJCA tax charge of $320 million and a $95
million after-tax charge related to hurricane damage. The increase in third quarter 2006 net income
principally can be attributed to higher sales volumes, higher local selling prices, and lower fixed
costs. These benefits were partly offset by the impact of higher energy and ingredient costs.
For the nine months ended September 30, 2006, Net income was $2,277 million, compared to $1,900
million in the prior year. 2006 year-to-date Net income reflects the higher sales volume and USD
selling prices that offset higher ingredient costs, and lower fixed cost. Net income in 2005
reflects a hurricane charge and the related impact of hurricane business interruption.
Earnings per Share - Diluted
Third quarter 2006 Earnings per share were $.52 compared to a loss of $.09 in the prior year,
reflecting higher net income and the benefit of a 7 percent reduction in the number of average
shares outstanding in the quarter. The lower number of average outstanding shares reflects
purchases made under the companys $5 billion share repurchase program. See Note 8 to the interim
Consolidated Financial Statements for further details.
For the nine months ended September 30, 2006, Earnings per share were $2.44 compared to $1.89 in
the prior year, reflecting an increase of $377 million in Net income and a 7 percent reduction in
the number of average shares outstanding in the period.
Corporate Outlook
The companys outlook for earnings per share for the year 2006 is about $2.86 per share.
Management anticipates that continued pricing strength and new product introductions, combined with
fixed cost control and modest volume growth will more than offset higher energy and ingredient
costs.
29
New Accounting Standard
During the first quarter 2006, the company adopted the provisions of Statement of Financial
Accounting Standard (SFAS) No. 123(R), Share-Based Payment. The adoption of this standard did
not have a material impact on the companys results of operations for the three-and-nine months
ended September 30, 2005.
Additional information related to the companys adoption of SFAS No. 123(R) is included in Note 2
to the interim Consolidated Financial Statements.
Accounting Standards Issued Not Yet Adopted
See Note 1 to the interim Consolidated Financial Statements for a description of recent accounting
pronouncements.
Segment Reviews
Summarized below are comments on individual segment sales and pretax operating income (PTOI) for
the three- and nine-month periods ended September 30, 2006, compared with the same periods in 2005.
Segment sales include transfers and pro rata share of equity affiliates sales. Segment PTOI is
defined as operating income before income taxes, minority interests, exchange gains (losses),
corporate expenses, and interest.
Agriculture & Nutrition - Third quarter sales of $967 million were 3 percent lower than third
quarter 2005 on nearly 3 percent lower volume and slightly lower USD selling prices. Results were
primarily driven by lower seed sales in Brazil, as well as continued price pressure in the chemical
industry. Market share gains in Brazil were more than offset by uncertainty over financing, which
moved some expected third quarter sales into the fourth quarter. The cotton market for the
companys Indoxacarb insecticide in South Asia continues to be challenged by the penetration of
insect resistant crops. Volume and price gains were realized in the U.S. and European cereal crop
protection markets as well as for rice crops in Japan. PTOI for the third quarter was a loss of
$158 million, which includes a $15 million gain on the sale of certain intangible assets, versus a
loss of $134 million in the prior year. PTOI reflects the decrease in sales, a less favorable
product mix and slightly higher fixed production costs. COGS was adversely affected by 2006 seed
sales produced in 2005 under an appreciated Brazilian Real.
For the nine months ended September 30, 2006, sales were $5.2 billion, a 4 percent decline over the
same period last year reflecting a 2 percent decline in USD selling prices and a 2 percent decline
in volume. The volume decline is almost equal in seed products and crop protection products.
Lower chemical sales reflect competitive pressure from generic brands and an overall decrease in
the market size for crop protection products. Seed corn units are down compared to last year due
to decreased acres and slightly lower market share, partially offset by strong increases in soybean
and oilseed volumes. PTOI for the first nine months of 2006 was $858 million versus $1,134
million in the same period last year. The decrease in PTOI reflects the sales decline and higher
production costs across most of the segment. Year to date 2006 PTOI includes income of $73 million
related to technology transfers, licensing agreements and asset sales.
Coatings & Color Technologies Sales in the third quarter of 2006 were $1.6 billion compared to
$1.5 billion last year. The 8 percent increase in sales over last year reflects record volume for
the quarter for TiO2 and full recovery from the 2005 hurricane Katrina business
interruption. Volume increases outside of North America, in part attributable to recovery from the
hurricane impact in 2005, more than offset weaker sales volume in North America particularly in the
automotive OEMs. 2006 third quarter sales reflect 3 percent higher USD selling prices that offset
increases in raw materials. Third quarter PTOI was $276 million, which includes $43 million in
insurance recovery, as compared to PTOI of $26 million last year which reflected a charge of $113
million related to hurricane damage. PTOI improvement also reflects the higher selling prices and
significantly lower fixed costs.
Sales in the first nine months of 2006 were $4.7 billion, up 3 percent from the same period last
year. Year to date sales reflect 1 percent volume growth and 2 percent higher USD selling
prices. Sales growth in industrial markets offset weakened volumes in automotive OEMs. Year to
date PTOI was
30
$513 million as compared to $375 million last year. 2006 results include a
restructuring charge of $135 million and $20 million primarily
for accelerated depreciation related to the
transformation plan that was initiated during the first quarter of 2006. (See Note 5 to the
interim Consolidated Financial Statements for a discussion of this plan.) Year over year
improvement in PTOI reflects pricing programs that offset higher raw material costs, and the
aforementioned hurricane related components in both years.
Electronic & Communication Technologies - Third quarter 2006 sales were $955 million, up
4 percent over third quarter last year on 2 percent higher USD selling prices and 2 percent higher
volume. Price increases largely reflect the pass-through of precious metal ingredient cost for
electronic product
offerings. Volume growth in wire and cable, semiconductor and photovoltaic product offerings have
been partly offset by lower volumes for refrigerants, reflecting increased competition. Third
quarter PTOI was $135 million as compared to $145 million in the prior year reflecting portfolio
mix, margin pressure and higher fixed costs including investment in growth and expansion.
Year-to-date sales of $2.9 billion were 5 percent higher than the same period last year primarily
for electronic products, reflecting 3 percent higher volumes and 2 percent higher USD selling
prices. PTOI was $467 million for the first nine months of 2006 compared to $472 million in the
prior year which included a $48 million gain on the disposition of the companys interest in DuPont
Photomasks, Inc. The segment earnings in 2006 benefited from solid growth in micro circuit and
printed circuit materials, semiconductor fabrication and strong results for monomers and
copolymers, partly offset by erosion in inkjet sales and pricing pressures in refrigerants.
Performance Materials - Sales of $1.7 billion were 13 percent higher in the third quarter of 2006
than in the third quarter 2005. Sales growth reflects 7 percent higher USD selling prices and 6
percent higher volumes. Sales were up in all regions. Approximately one-third of the volume
increase is attributable to recovery from the hurricane impact in 2005. Volume increased across
all markets as compared to third quarter last year demonstrating the diversity of product
applications despite lower North American Auto builds. Third quarter PTOI of $172 million reflects
stronger sales including price improvement and lower fixed costs. PTOI for third quarter 2005 was
$68 million, including a charge for hurricane damage of $11 million.
Year-to-date sales were $5.2 billion in both 2006 and 2005. Year-to-date sales in 2005 included
$386 million related to elastomers businesses transferred to Dow on June 30, 2005. Excluding these
sales from the comparison, 2006 year-to-date sales are up 9 percent and reflect a 5 percent volume
increase and a 4 percent increase in USD selling prices. PTOI for the first nine months of 2006
was $502 million. PTOI includes a first quarter $27 million impairment charge and reflects
increased selling prices that have not fully offset the ingredient cost increases. Cost controls
have reduced fixed costs on a year-to-date basis. 2005 PTOI of $469 million included an $11
million hurricane charge, $47 million in operating income related to certain DDE assets sold, a $23
million gain on sale of these DDE assets, and a charge of $34 million related to the planned
consolidation of the companys neoprene operations at its LaPlace, Louisiana, facility. The timing
for the consolidation has been delayed due to availability of construction employees and equipment
in the post-hurricane Gulf States rebuilding effort. As a result, manufacturing operations at the
Louisville, Kentucky, site could extend beyond the previously announced March 2007 shutdown by 3 to
6 months.
Safety & Protection - Third quarter sales of $1.4 billion were 11 percent higher than third quarter
sales last year, reflecting an 8 percent increase in USD selling prices, which offset raw material
cost increases, and a 3 percent volume growth, two-thirds of which is attributable to recovery from
the 2005 hurricane interruption. Sales grew across all geographic regions particularly in
emerging markets. Market demand for most of the segments product offerings more than offset
slowing demand in the U.S. construction industry. Third quarter PTOI was $292 million and includes
$7 million in insurance recovery related to 2005 hurricane damage. PTOI for the third quarter of
last year was $256 million, which included a gain of $31 million resulting from the sale of
non-core assets in North America, and a charge of $22 million related to the hurricanes. PTOI
improvement also reflects higher selling prices and fixed cost control.
Year-to-date sales of $4.2 billion were 7 percent higher than the same period last year, reflecting
2 percent higher volumes and 5 percent higher USD selling prices. Price increases offset increases
in raw material costs across the platform. Volumes increased in all geographic regions across the
segment offerings except where planned exits of lower margin products occurred. PTOI for year to
date 2006 was
31
$871 million including a $7 million insurance recovery, versus $770 million in the
prior year, which included the gain on sale of assets described above and the aforementioned
hurricane charge.
Liquidity & Capital Resources
Management believes that the companys ability to generate cash and access the capital markets will
be adequate to meet anticipated future cash requirements to fund working capital, capital spending,
dividend payments and other cash needs for the foreseeable future. The companys liquidity needs
can be met through a variety of independent sources, including: Cash provided by operating
activities, Cash and cash equivalents, Marketable debt securities, commercial paper, syndicated
credit lines, bilateral credit lines, equity and long-term debt markets, and asset sales. The
companys relatively low long-term borrowing level, strong financial position and credit ratings
provide excellent access to these markets.
The company continually reviews its debt portfolio for appropriateness and occasionally may
rebalance it to insure adequate liquidity and an optimum debt maturity schedule.
Cash provided by operating activities was $763 million for the nine months ended September 30,
2006, versus $171 million used for operating activities for the same period ended in 2005. The
increase in cash provided by operating activities is primarily due to higher net income in 2006 and
a reduction in contributions made to pension plans, partially offset by higher accounts receivable
and timing of tax payments. In the third quarter of 2005, the company made a $1 billion
contribution to the principal U.S. pension plan.
Cash used for investing activities was $897 million for the nine months ended September 30, 2006
compared to $495 million for the same period last year. The increase reflects higher purchases of
property, plant and equipment and lower proceeds from the sale of assets. Settlements of forward
exchange contracts associated with the companys hedging activities were largely offset by
revaluation of the items being hedged, which are reflected in the appropriate categories in the
Consolidated Statement of Cash Flows.
Cash used for financing activities was $880 million for the nine months ended September 30, 2006,
compared to $2,956 million provided by financing activities for the same period last year. This
reduction in financing activities cash flows principally reflects lower borrowing needs to meet the
companys global funding requirements.
Dividends paid to shareholders during the first nine months of 2006 totaled $1,035 million. In
October 2006, the companys Board of Directors declared a fourth quarter common stock dividend of
$0.37 per share, which is the same as the dividend paid in the third quarter 2006. The fourth
quarter dividend was the companys 409th consecutive quarterly dividend since the
companys first dividend in the fourth quarter 1904.
Stock Repurchases
The companys Board of Directors authorized a $2 billion share buyback plan in June 2001. During
the first nine months of 2006, there were no purchases of stock under this program. To date the
company has purchased 20.5 million shares at a total cost of $962 million. Management expects to
continue purchasing stock under this buyback plan to offset dilution from shares issued under
employee compensation plans; however, a timeline for the buyback of the remaining stock under this
program has not been established.
In addition to the plan described above, in October 2005 the Board of Directors authorized a $5
billion share buyback plan. The company entered into an accelerated share repurchase agreement with
Goldman Sachs & Co. (Goldman Sachs) under which the company purchased and retired 75.7 million
shares of DuPonts outstanding common stock from Goldman Sachs on October 27, 2005 at a price of
$39.62 per share, with Goldman Sachs purchasing an equivalent number of shares in the open market
over the following nine-month period.
On July 27, 2006, Goldman Sachs completed its purchase of 75.7 million shares of DuPonts common
stock at a volume weighted average price (VWAP) of $41.99 per share. Upon the conclusion of the
agreement, the company was required to make a settlement payment to Goldman Sachs of $180 million,
which the company elected to pay in cash. The final settlement price was based upon the difference
32
between the VWAP per share for the nine-month period, which ended July 27, 2006, and the purchase
price of $39.62 per share. The amount paid to settle the contract was recorded as a reduction to
Additional paid-in capital during the third quarter 2006. In addition, the company made open
market purchases of its shares in the third quarter for
$100 million at an average price of $42.27 per share, bringing purchases to date
under the $5 billion share buyback plan to about $3.3 billion. The company anticipates completing
the remaining $1.7 billion of the program, consistent with its financial discipline principles, by
the end of 2007.
Cash and Cash Equivalents and Marketable Debt Securities
Cash and cash equivalents and Marketable debt securities were $724 million at September 30, 2006,
versus $1.9 billion at December 31, 2005. The decrease was due to cash used to fund normal
seasonal working capital needs, principally in the Agriculture & Nutrition segment.
Short- and Long-Term Borrowings and Capital Lease Obligations
Total debt at September 30, 2006 was $8.8 billion, an increase of $0.6 billion from December 31,
2005. The increase in debt was used to fund normal seasonal working capital needs, principally in
the Agriculture & Nutrition segment.
Net Debt
At September 30, 2006, net debt was $8.0 billion compared to $6.3 billion at December 31, 2005.
The company defines net debt as total debt less Cash and cash equivalents and Marketable debt
securities. Management believes that net debt is meaningful because it provides the investor with
a more holistic view of the companys liquidity and debt position since the companys cash balance
is available to meet operating and capital needs, as well as to provide liquidity around the world.
Net debt also allows the investor to more easily compare cash flow between periods without
adjusting for changes in cash and debt.
The following table reconciles the differences from total debt to net debt:
|
|
|
|
|
|
|
|
|
(Dollars in millions) |
|
September 30, |
|
|
December 31, |
|
|
|
2006 |
|
2005 |
Commercial paper |
|
$ |
1,958 |
|
|
$ |
- |
|
Long-term debt due in one year |
|
|
1,029 |
|
|
|
986 |
|
Other short-term debt |
|
|
255 |
|
|
|
411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term debt |
|
|
3,242 |
|
|
|
1,397 |
|
Long-term debt |
|
|
5,509 |
|
|
|
6,783 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total debt |
|
|
8,751 |
|
|
|
8,180 |
|
Less: Cash and cash equivalents |
|
|
718 |
|
|
|
1,736 |
|
Less: Marketable debt securities |
|
|
6 |
|
|
|
115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net debt |
|
$ |
8,027 |
|
|
$ |
6,329 |
|
|
|
|
|
|
33
The following table summarizes changes in net debt for the nine-month period ending September 30,
2006:
|
|
|
|
|
(Dollars in millions) |
|
|
|
|
|
Net debt January 1, 2006 |
|
$ |
6,329 |
|
Cash provided by continuing operations |
|
|
(763 |
) |
Purchases of
property, plant & equipment
and investments in affiliates |
|
|
1,107 |
|
Net payments for businesses acquired |
|
|
57 |
|
Proceeds from sales of assets |
|
|
(80 |
) |
Forward exchange contract settlements |
|
|
(50 |
) |
Dividends paid to stockholders |
|
|
1,035 |
|
Proceeds from exercise of stock options |
|
|
(45 |
) |
|
|
|
|
|
Acquisition of treasury stock |
|
|
280 |
|
Other |
|
|
157 |
|
|
|
|
|
|
|
|
Increase in net debt |
|
|
1,698 |
|
|
|
|
|
|
|
|
Net debt September 30, 2006 |
|
$ |
8,027 |
|
|
|
Guarantees and Off-Balance Sheet Arrangements
For detailed information related to Guarantees, Indemnifications, Obligations for Equity Affiliates
and Others, Certain Derivative Instruments, and Synthetic Leases, see page 42 to the companys 2005
Annual Report on Form 10-K, and Note 11 of the interim Consolidated Financial Statements. See
discussion of accelerated share repurchase agreement under Stock Repurchases section above for
additional information.
Contractual Obligations
Information related to the companys contractual obligations at December 31, 2005 can be found on
page 45 of the companys Annual Report on Form 10-K. Updated information with respect to certain of
the companys significant contractual obligations is summarized in the following table:
Contractual Obligations at September 30, 2006:
(Dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due In |
|
|
Total at |
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
2007- |
|
2009- |
|
2011 and |
|
|
2006 |
|
2006* |
|
2008 |
|
2010 |
|
Beyond |
Long-term debt, including
current portion |
|
$ |
6,521 |
|
|
$ |
257 |
|
|
$ |
2,149 |
|
|
$ |
2,374 |
|
|
$ |
1,741 |
|
|
Expected cumulative cash
requirements for interest
payments through maturity
|
|
$ |
1,876 |
|
|
$ |
93 |
|
|
$ |
600 |
|
|
$ |
300 |
|
|
$ |
883 |
|
|
|
|
* |
|
Represents 3 months ending December 31, 2006. |
34
Long-Term Employee Benefits
The company has various obligations to its employees and retirees. The company maintains
retirement-related programs in many countries that have a long-term impact on the companys
earnings and cash flows. These plans are typically defined benefit pension plans, and medical,
dental and life insurance benefits for pensioners and survivors. DuPont is exploring alternative
solutions to meet its global pension obligations in the most cost effective manner possible as
demographics, life expectancy and country-specific pension funding rules change. The Pension
Protection Act of 2006 (the Act) was signed into law in the U.S in August 2006. The Act
introduces new funding requirements for single-employer defined benefit pension plans, provides
guidelines for measuring pension plan assets and pension obligations for funding purposes,
introduces benefit limitations for certain underfunded plans, and raises tax deduction limits for
contributions to retirement plans. The new funding requirements become effective for plan years
beginning after December 31, 2007. The company continues to evaluate the effects of the Act.
Although significant regulatory guidance will be required prior to its 2008 effective date, the
company does not anticipate that the Act will have a material near-term impact on its required
contributions.
In August, 2006, the company announced major changes to its principal U.S. pension plan and savings
plan. Employees hired after December 31, 2006 will participate in the enhanced savings plan, but
not in the pension plan. Active employees on the rolls as of December 31, 2006 will participate in
the enhanced savings plan effective January 1, 2008, and will continue to accrue benefits in the
pension plan, but at a reduced rate. In addition, company-paid post-retirement survivor benefits
will not continue to grow after December 31, 2007. Additional information related to these changes
is included in Note 14 to the Interim Consolidated Financial Statements.
PFOA
DuPont manufactures fluoropolymer resins and dispersions as well as fluorotelomers marketing many
of them under the Teflon® and Zonyl® brands. The
fluoropolymer resin and
dispersion businesses are part of the Electronic & Communication Technologies segment; the
fluorotelomers business is part of the Safety & Protection segment.
Fluoropolymer resins and dispersions are high-performance materials with many end uses including
architectural fabrics, telecommunications and electronic wiring insulation, automotive fuel
systems, computer chip processing equipment, weather-resistant/breathable apparel and non-stick
cookware. Fluorotelomers are used to make soil, stain and grease repellants for paper, apparel,
upholstery and carpets as well as firefighting foams and coatings.
A form of PFOA (perfluorooctanoic acid and its salts, including the ammonium salt) is used as a
processing agent to manufacture fluoropolymer resins and dispersions. For over 50 years, DuPont
purchased its PFOA needs from a third party, but beginning in the fall of 2002, it began producing
PFOA to support the manufacture of fluoropolymer resins and dispersions. PFOA is not used in the
manufacture of fluorotelomers; however, it is an unintended by-product present at trace levels in
some fluorotelomer-based products.
DuPont Performance Elastomers, LLC uses PFOA in its manufacture of KalrezÒ
perfluoroelastomer parts and certain fluoroelastomers marketed under the VitonÒ
trademark. The wholly owned subsidiary is a part of the Performance Materials segment.
PFOA is bio-persistent and has been detected at very low levels in the blood of the general
population. As a result, the EPA initiated a process to enhance its understanding of the sources
of PFOA in the environment and the pathways through which human exposure to PFOA is occurring. In
2003, the EPA issued a preliminary risk assessment on PFOA that focuses on the exposure of the U.S.
general population to PFOA and possible health effects, including developmental toxicity concerns.
On January 12, 2005, the EPA issued a draft risk assessment on PFOA. The draft stated that cancer
data for PFOA may be best described as suggestive evidence of carcinogenicity, but not sufficient
to assess human carcinogenic potential under the EPAs Guidelines for Carcinogen Risk Assessment.
Under the Guidelines, the descriptor suggestive is typically applied to agents if animal testing
finds any evidence that exposure causes tumors in one species of animal.
35
The EPA requested that the Science Advisory Board (SAB) review and comment on the scientific
soundness of this assessment. On May 31, 2006, the SAB released
its report setting forth the view, based on laboratory studies in rats, that the human carcinogenic potential of PFOA is more
consistent with the EPAs descriptor of likely to be carcinogenic as defined in the Guidelines
for Carcinogen Risk Assessment. However, in its report the SAB indicated that additional data
should be considered before the EPA finalizes its risk assessment of PFOA. Under the Guidelines
the likely descriptor is typically applied to agents that have tested positive in more than one
species, sex, strain, site or exposure route with or without evidence of carcinogenicity in humans.
The EPA has acknowledged that it will consider additional data and has indicated that another SAB
review will be sought after the EPA makes its risk assessment. DuPont disputes the cancer
classification recommended in the SAB report.
In February 2006, a petition was submitted to place PFOA under California Proposition 65 which
requires the State to publish a list of chemicals known to cause cancer, birth defects or other
reproductive harm. DuPont disagrees with placing PFOA under Proposition 65 because such actions
would not adequately reflect human health data which to date demonstrates no increase in cancer
rates known to be associated with PFOA.
The EPA has stated that there remains considerable scientific uncertainty regarding potential risks
associated with PFOA. The EPA has also stated that it does not believe that there is any reason
for consumers to stop using any related products because of concerns about PFOA. Currently, PFOA
is not regulated by the EPA and there are no regulatory actions pending that would prohibit its
production or use. However, there can be no assurance that the EPA or any other regulatory entity
will not in the future choose to regulate or prohibit the production or use of PFOA. Products
currently manufactured by the company representing approximately $1 billion of 2005 revenues could
be affected by any such regulation or prohibition.
DuPont respects the EPAs position raising questions about exposure routes and the potential
toxicity of PFOA. DuPont and other companies have outlined plans to
continue research, as well as emission reduction and product stewardship activities to help address the EPAs
questions. In January 2006, DuPont pledged its commitment to the EPAs 2010/15 PFOA Stewardship
Program. The EPA program asks participants (1) to commit to achieve, no later than 2010, a 95
percent reduction in both facility emissions and product content levels of PFOA, PFOA precursors,
and related higher homologue chemicals and (2) to commit to working toward the elimination of PFOA,
PFOA precursors, and related higher homologue chemicals from emissions and products by no later
than 2015. In August 2006, EPA issued reporting guidelines for the Program.
Since January 2006, DuPont has developed its baseline reporting data for submission to the EPA by
October 31, 2006, and has refined its Program commitments based on a careful review of the data,
the subsequently issued EPA Program guidelines, and the state of the technology. Key elements of
the DuPont commitment to EPA include reducing global emissions from manufacturing facilities by 97
percent by 2007 (which incorporates the substantial achievement of 90 percent reduction already
realized through DuPonts ongoing reduction program); reducing PFOA content in fluoropolymer
dispersions faster and further than the goals set by the Program; and, by 2010, reducing PFOA
content and any residual impurities in fluorotelomer products that could break down to PFOA.
Consistent with EPAs Program guidelines, PFOA product content and US plant PFOA emission caps are
not part of DuPont commitments going forward.
DuPont will work individually and with others in the industry to inform EPAs regulatory
counterparts in the European Union, Canada, China and Japan about these activities and PFOA in
general, including emissions reductions from DuPonts facilities, reformulation of the companys
fluoropolymer dispersions, and new manufacturing processes for fluorotelomers products. DuPont has
developed technology that can reduce the PFOA content in fluoropolymer dispersions by 97 percent.
DuPont is offering the technology to fluoropolymer manufacturers globally on a royalty-free basis.
DuPont is in the process of launching low PFOA dispersion products. In addition, the company
started up a new process at its Pascagoula, Mississippi manufacturing site that will reduce PFOA
trace levels in fluorotelomer products even further. The company expects products based on this
new technology to be available in late 2006.
Based on health and toxicological studies conducted by the company and other researchers, DuPont
believes the weight of evidence indicates that PFOA exposure does not pose a health risk to the
general public. To date no human health effects are known to be caused by PFOA, even in workers
who have significantly higher exposure levels than the general population. DuPont is conducting a
two-phase employee health study on PFOA for more than 1,000 workers at its Washington Works site
located
36
near Parkersburg, WV. Results from the first phase of this study for more than 100 workers
indicate no association between exposure to PFOA and most of the health parameters that were
measured. The
second phase is a mortality study that involves the examination of all causes of death in more than
6,000 employees who worked at the Washington Works site during its more than fifty years of
operation. The second phase was completed during the third quarter of 2006 and showed no increase
in mortality in workers exposed to PFOA. Based on the observation of a modest increase in some
lipid fractions in the studys first phase, the second phase included a more detailed analysis of
heart disease. No overall increase in deaths related to heart disease was found.
DuPont has established reserves in connection with certain PFOA litigation matters. See Note 11 to
the interim Consolidated Financial Statements.
Item 4. CONTROLS AND PROCEDURES
a) |
|
Evaluation of Disclosure Controls and Procedures |
|
|
|
The company maintains a system of disclosure controls and procedures
for financial reporting to give reasonable assurance that information
required to be disclosed in the companys reports submitted under the
Securities Exchange Act of 1934 is recorded, processed, summarized and
reported within the time periods specified in the rules and forms of
the Securities and Exchange Commission. These controls and procedures
also give reasonable assurance that information required to be
disclosed in such reports is accumulated and communicated to
management to allow timely decisions regarding required disclosures. |
|
|
|
As of September 30, 2006, the companys Chief Executive Officer (CEO)
and Chief Financial Officer (CFO), together with management, conducted
an evaluation of the effectiveness of the companys disclosure
controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of
the Exchange Act. Based on that evaluation, the CEO and CFO concluded
that these disclosure controls and procedures are effective. |
|
b) |
|
Changes in Internal Control over Financial Reporting |
|
|
|
There has been no change in the companys internal control over
financial reporting that occurred during the quarter ended September
30, 2006 that has materially affected the companys internal control
over financial reporting.
|
37
PART II. OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
BenlateÒ
Information related to this matter is included in Note 11 to the companys interim Consolidated
Financial Statements under the heading BenlateÒ.
PFOA: U.S. Environmental Protection Agency (EPA) and Class Actions
Information related to this matter is included in Note 11 to the companys interim Consolidated
Financial Statements under the heading PFOA.
Elastomers Antitrust Matters
Information related to this matter is included in Note 11 to the companys interim Consolidated
Financial Statements under the heading Elastomers Antitrust Matters.
Environmental Proceedings
Acid Plants New Source Review Enforcement Action
In 2003, the EPA issued a Notice of Violation and Finding of Violation for the companys Fort
Hill sulfuric acid plant in North Bend, Ohio. The EPA conducted a review of capital projects at
the plant over the past twenty years. Based on its review, the EPA believes that two of the
projects triggered a requirement to meet the New Source Performance Standards for sulfuric acid
plants and that the company should have sought a permit under the New Source Review requirements of
the Clean Air Act (CAA). In July 2004, the EPA issued a Notice of Violation for the James River
acid plant with similar allegations. The company vigorously disagrees with the EPAs findings
because the EPA continues to change its interpretation of these rules and requirements without
going through the required process to amend them. The courts are split on these interpretations.
The company has a total of four sulfuric acid plants that use similar technology.
In October, EPA, several states and DuPont reached an agreement in principle to settle this matter
under which DuPont will pay a total of $4.125 million in civil penalties, which may include
supplemental environmental projects, to the U.S. federal government and the states. DuPont also
will either retrofit the four acid plants over the next 6 years or shut certain of them down. The
agreement is subject to the parties negotiation of acceptable written terms and to various
governmental approvals
Chambers Works Plant, New Jersey
Information related to this matter is included on page 36, Item 1, to the companys Quarterly
Report on Form 10-Q for the period ending June 30, 2006.
PFOA: West Virginia and Ohio Departments of Environmental Protection
Information related to this proceeding is included on page 12, Item 3, to the companys 2005 Annual
Report on Form 10-K.
Sabine River Works, Orange, Texas
On November 19, 2004, the company received a Notice of Enforcement Action (NoE) from the Texas
Commission on Environmental Quality (TCEQ) regarding its Sabine River Works facility located in
Orange, TX. The Notice contained 45 allegations relating to reportable and non-reportable emission
events from 2002 through 2004 and sought an administrative penalty of $134,852. In addition to
this NoE, the company had received 6 other NoEs raising allegations of air, water and monitoring
violations dating back to 2001. The company has reached an agreement with the TCEQ combining all
of these enforcement actions and settling the allegations for a total penalty of $176,575. As a
condition of the agreement the company did not agree to the allegations and the allegations remain
in dispute. Under the agreement $88,288 will be paid as a penalty to the TCEQ with the remaining
$88,287 being paid to a local Supplemental Environmental Project.
Gibson City, Illinois
Information related to this proceeding is included on page 12, Item 3, to the companys 2005 Annual
Report on Form 10-K.
38
Item 1A. RISK FACTORS
The company operates in markets that involve significant risks, many of which are beyond the
companys control. Based on current information, the company believes that the following
identifies the most significant risk factors that could affect its businesses. However, the risks
and uncertainties the company faces are not limited to those discussed below. Additional risks and
uncertainties not presently known to the company or that the company currently believes to be
immaterial also could affect its businesses. Past financial performance may not be a reliable
indicator of future performance and historical trends should not be used to anticipate results or
trends in future periods.
Price increases for energy costs and raw materials could have a significant impact on the companys
ability to sustain and grow earnings.
The companys manufacturing processes consume significant amounts of energy and hydrocarbon-based
raw materials the costs of which primarily reflect market prices for oil and natural gas. These
prices are subject to worldwide supply and demand as well as other factors beyond the control of
the company. Significant variations in the cost of energy and raw materials affect the companys
operating results from period to period. When possible, the company purchases raw materials
through negotiated long-term contracts to minimize the impact of price fluctuations. The company
has taken actions to offset the effects of higher energy and raw material costs through selling
price increases, productivity improvements and cost reduction programs. Success in offsetting
higher raw material costs with price increases is largely influenced by competitive and economic
conditions and could vary significantly depending on the market served. If the company is not able
to fully offset the effects of higher energy and raw material costs, it could have a significant
impact on the companys financial results.
Failure to develop and market new products could impact the companys competitive position and have
an adverse affect on the companys financial results.
The companys operating results are largely dependent on its ability to renew its pipeline of new
products and services and to bring those products and services to market. This ability could be
adversely affected by difficulties or delays in product development such as the inability to
identify viable new products, successfully complete research and development, obtain relevant
regulatory approvals, obtain intellectual property protection, or gain market acceptance of new
products and services. Because of the lengthy development process, technological challenges and
intense competition, there can be no assurance that any of the products the company is currently
developing, or could begin to develop in the future, will achieve substantial commercial success.
Sales of the companys new products could replace sales of some of its current products, offsetting
the benefit of even a successful product introduction.
The companys results of operations could be adversely affected by litigation and other commitments
and contingencies.
The company faces risks arising from various litigation matters unasserted and asserted, including
but not limited to product liability claims, patent infringement claims and antitrust claims. The
company has noted a nationwide trend in purported class actions against chemical manufacturers
generally seeking relief such as medical monitoring, property damages, off-site remediation and
punitive damages arising from alleged environmental torts without claiming present personal
injuries. Various factors or developments can lead to changes in current estimates of liabilities
such as a final adverse judgment, significant settlement or changes in applicable law. A future
adverse ruling or unfavorable development could result in future charges that could have a material
adverse effect to the company. An adverse outcome in any one or more of these matters could be
material to the companys Consolidated Financial Statements. For further information see Part I,
Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations
subtitled PFOA and Note 11 to the companys interim Consolidated Financial Statements.
39
In the ordinary course of business, the company may make certain commitments, including
representations, warranties, indemnities and guarantees of third party obligations. If the company
were required to make payments as a result, they could exceed the amounts accrued, thereby
adversely affecting the companys results of operations. For further information see Note 11 to
the companys interim Consolidated Financial Statements.
The companys operations are subject to extensive environmental laws and regulations.
The companys operations are subject to various federal, state and international laws and
regulations governing the environment, including the discharge of pollutants into the air and water
and the management and disposal of hazardous substances. The company could incur substantial
costs, including cleanup costs, fines and civil or criminal sanctions, third-party property damage
or personal injury claims. The costs of complying with complex environmental laws and regulations,
as well as internal voluntary programs, are significant and will continue to be so for the
foreseeable future. The ultimate costs under environmental laws and the timing of these costs are
difficult to predict. The companys accruals for such costs and liabilities may not be adequate
because the estimates on which the accruals are based depend on a number of factors including the
nature of the allegation, the complexity of the site, site geology, the nature and extent of
contamination, the type of remedy, the outcome of discussions with regulatory agencies and other
Potentially Responsible Parties (PRPs) at multi-party sites, and the number of financial viability
of other PRPs. It is the companys policy that all of its operations fully meet or exceed legal
and regulatory requirements for protecting the environment. For further information see Part II,
Item 1 Legal Proceedings, Note 11 to the companys interim Consolidated Financial Statements and
Part II, Item 7 Managements Discussion and Analysis of Financial Condition and Results of
Operations entitled Environmental Matters to the Companys Annual Report on Form 10-K.
The companys ability to generate sales from genetically enhanced products, particularly seeds and
other agricultural products, could be adversely affected by market acceptance, government policies,
rules or regulations and competition.
The company is using biotechnology to create and improve products, particularly in its Agriculture
& Nutrition segment. Demand for these products could be affected by market acceptance of
genetically modified products as well as governmental policies, laws and regulations that affect
the development, manufacture and distribution of products, including the testing and planting of
seeds containing biotechnology traits, and the import of crops grown from those seeds.
The company competes with major, global companies that have strong intellectual property estates
supporting the use of biotechnology to enhance products, particularly in the agricultural products
and production markets. Speed in discovering and protecting new technologies, and bringing
products based on them to market is a significant competitive advantage. Failure to predict and
respond effectively to this competition could cause the companys existing or candidate products to
become less competitive adversely affecting sales.
Changes in government policies and laws or worldwide economic conditions could adversely affect the
companys financial results.
Sales outside the U.S. constitute more than half of the companys revenue. The company anticipates
that international sales will continue to represent a substantial portion of its total sales and
that continued growth and profitability will require further international expansion. The
companys financial results could be affected by changes in trade, monetary and fiscal policies,
laws and regulations, or other activities of U.S. and non-U.S. governments, agencies and similar
organizations. These conditions include but are not limited to changes in a countrys or regions
economic or political conditions, trade regulations affecting production, pricing and marketing of
products, local labor conditions and regulations, reduced protection of intellectual property
rights in some countries, changes in the regulatory or legal environment, restrictions on currency
exchange activities, burdensome taxes and tariffs and other trade barriers. International risks
and uncertainties, including changing social and economic conditions as well as terrorism,
political hostilities and war, could lead to reduced international sales and reduced profitability
associated with such sales.
40
Economic factors, including inflation and fluctuations in currency exchange rates, interest rates,
and commodity prices could affect the companys financial results.
The company is exposed to fluctuations in currency exchange rates, interest rates and commodity
prices. Because the company has significant international operations, there are a large number of
currency transactions that result from international sales, purchases, investments, and borrowings.
The company actively manages currency exposures that are associated with monetary asset positions,
committed currency purchases and sales, and other assets and liabilities created in the normal
course of business. Failure to successfully manage these risks could have an adverse impact on the
companys financial position, results of operations and cash flows.
Business disruptions could seriously impact the companys future revenue and financial condition
and increase costs and expenses.
Business disruptions, including supply disruptions, increasing costs for energy, temporary plant
and/or power outages, natural disasters and severe weather events and information technology system and network disruptions, could seriously harm the
companys operations as well as the operations of its customers and supplies. Although it is
impossible to predict the occurrences or consequences of any such events, they could result in
reduced demand for the companys products, make it difficult or impossible for the company to
deliver products to its customers or to receive raw materials from suppliers, create delays and
inefficiencies in the supply chain and result in the need to impose employee travel restrictions.
The impact from business disruptions could significantly increase the cost of doing business or
otherwise adversely impact the companys financial performance.
Inability to protect and enforce the companys intellectual property rights could adversely affect
the companys financial results.
Intellectual property rights are important to the companys business. The company attempts to
protect its intellectual property rights in jurisdictions in which its products are produced or
used and in jurisdictions into which its products are imported. However, the company may be unable
to obtain protection for its intellectual property in key jurisdictions. Additionally, the company
has designed and implemented internal controls to restrict access to and distribution of its
intellectual property, including confidential information and trade secrets. Despite these
precautions, it is possible that unauthorized parties may access and use such property. When
misappropriation is discovered, the company reports such situations to the appropriate governmental
authorities for investigation and takes measures to mitigate any potential impact.
Failure to successfully implement acquisitions, joint ventures and strategic alliances could
adversely affect the companys financial results.
As part of its strategy for growth, the company has entered, and may continue to enter, into
arrangements with other companies to expand product and service offerings, increase market access,
improve operating costs, and realize other benefits. There can be no assurance that the company
will be successful in completing such arrangements. Furthermore, there can be no assurance that any
such arrangements that are implemented will yield the expected benefits.
The company may not be able to successfully implement its productivity and cost-reduction
initiatives.
The company has undertaken and may continue to undertake productivity initiatives, including cost
reduction programs, organizational restructurings and Six Sigma projects, to improve performance
and generate cost savings. There can be no assurance that these will be completed or beneficial to
the company. Also, there can be no assurance that any estimated cost savings from such activities
will be realized.
41
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table summarizes information with respect to the companys purchases of its common
stock during the three months ended September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2001 Plan |
|
|
2005 Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Approximate |
|
|
|
|
|
|
Approximate |
|
|
|
|
|
|
|
|
|
|
|
Total Number |
|
|
Value of |
|
|
Total Number |
|
|
Value of |
|
|
|
|
|
|
|
|
|
|
|
of Shares |
|
|
Shares That |
|
|
of Shares |
|
|
Shares That |
|
|
|
|
|
|
|
|
|
|
|
Purchased as |
|
|
May Yet be |
|
|
Purchased as |
|
|
May Yet be |
|
|
|
|
|
|
|
Average |
|
|
Part of Publicly |
|
|
Purchased |
|
|
Part of Publicly |
|
|
Purchased |
|
|
|
Total Shares |
|
|
Price Paid |
|
|
Announced |
|
|
(Dollars in |
|
|
Announced |
|
|
(Dollars in |
|
Month |
|
Purchased |
|
|
Per Share |
|
|
Program1 |
|
|
millions) |
|
|
Program2 |
|
|
millions) |
|
September |
|
|
2,365,683 |
|
|
$ |
42.27 |
|
|
|
0 |
|
|
$ |
1,038 |
|
|
|
2,365,683 |
|
|
$ |
1,695 |
|
Total |
|
|
2,365,683 |
|
|
$ |
42.27 |
|
|
|
0 |
|
|
|
|
|
|
|
2,365,683 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
In June 2001, the Board of Directors authorized up to $2 billion for repurchases of the companys common stock.
There were no purchases of the companys common stock under this plan during the three months ended September 30,
2006. As of September 30, 2006, cumulative purchases of common stock under this plan are 20.5 million shares at a cost
of $962 million. There is no expiration date on the current authorization and no determination has been made by the
company to suspend or cancel purchases under the plan. |
|
2 |
|
In October 2005, the Board of Directors authorized a $5 billion share buyback plan. During the three months ended
September 30, 2006, the company purchased 2.4 million shares at a cost of $100 million. On October 24, 2005, the
company entered into an accelerated share repurchase agreement with Goldman, Sachs & Co. (Goldman Sachs)
under which the company purchased 75,719,334 shares of DuPonts common stock at a cost of $3.2 billion. As of
September 30, 2006, cumulative purchases of common stock under this plan are 78.1 million shares at a cost of $3.3
billion. There is no expiration date on the current authorization and no determination has been made by the company
to suspend or cancel purchases under the plan. |
Item 6. EXHIBITS
The exhibit index filed with this Form 10-Q is on pages 44-46.
42
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
E. I. DU PONT DE NEMOURS AND COMPANY |
|
|
|
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
Date:
|
|
November 3, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Jeffrey L. Keefer |
|
|
|
|
|
|
|
|
|
|
|
Jeffrey L. Keefer |
|
|
|
|
Executive Vice President Chief Financial Officer |
|
|
|
|
|
|
(As Duly Authorized Officer and |
|
|
|
|
Principal Financial and Accounting Officer) |
|
|
43
EXHIBIT INDEX
|
|
|
Exhibit |
|
|
Number |
|
Description |
3.1
|
|
Companys Restated Certificate of Incorporation
(incorporated by reference to Exhibit 3.1 of the companys
Annual Report on Form 10-K for the year ended December 31,
2002). |
|
|
|
3.2
|
|
Companys Bylaws, as last revised January 1, 1999
(incorporated by reference to Exhibit 3.2 of the companys
Annual Report on Form 10-K for the year ended December 31,
2003). |
|
|
|
4
|
|
The company agrees to provide the Commission, on request,
copies of instruments defining the rights of holders of
long-term debt of the company and its subsidiaries. |
|
|
|
10.1*
|
|
The DuPont Stock Accumulation and Deferred Compensation
Plan for Directors, as last amended effective January 1,
2006 (incorporated by reference to Exhibit 10.1 of the
companys Quarterly Report on Form 10-Q for the period
ended March 31, 2006). |
|
|
|
10.2*
|
|
Terms and conditions of time-vested restricted stock units
to non-employee directors and the companys Stock
Accumulation and Deferred Compensation Plan (incorporated
by reference to the companys Quarterly Report on Form 10-Q
for the period ended March 31, 2005). |
|
|
|
10.3*
|
|
Companys Supplemental Retirement Income Plan, as last
amended effective June 4, 1996 (incorporated by reference
to Exhibit 10.3 of the companys Annual Report on Form 10-K
for the year ended December 31, 2001). |
|
|
|
10.4*
|
|
Companys Pension Restoration Plan, as restated effective
July 17, 2006 (incorporated by reference to Exhibit 99.1 of
the companys Current Report on Form 8-K filed on July 20,
2006). |
|
|
|
10.5*
|
|
Companys Rules for Lump Sum Payments adopted July 17, 2006
(incorporated by reference to Exhibit 99.2 of the companys
Current Report on Form 8-K filed on July 20, 2006) |
|
|
|
10.6*
|
|
Companys Stock Performance Plan, as last amended effective
January 28, 1998 (incorporated by reference to Exhibit 10.4
of the companys Quarterly Report on Form 10-Q for the
period ended March 31, 2003). |
|
|
|
10.7*
|
|
Terms and conditions of stock options granted in 2006 under
the companys Stock Performance Plan (incorporated by
reference to Exhibit 10.6 of the companys Quarterly Report
on Form 10-Q for the period ended March 31, 2006). |
|
|
|
10.8*
|
|
Terms and conditions of performance-based restricted stock
units granted in 2006 under the companys Stock Performance
Plan (incorporated by reference to Exhibit 10.7 of the
companys Quarterly Report on Form 10-Q for the period
ended March 31, 2006). |
|
|
|
10.9*
|
|
Terms and conditions of time-vested restricted stock units
granted in 2006 under the companys Stock Performance Plan
(incorporated by reference to Exhibit 10.9 of the companys
Quarterly Report on Form 10-Q for the period ended March
31, 2006). |
|
|
|
10.10*
|
|
Companys Variable Compensation Plan, as last amended
effective April 30, 1997 (incorporated by reference to
pages A1-A3 of the companys Annual Meeting Proxy Statement
dated March 21, 2002). |
|
|
|
10.11*
|
|
Companys Salary Deferral & Savings Restoration Plan, as
last amended effective March 1, 2003 (incorporated by
reference to Exhibit 10.6 of the companys Quarterly Report
on Form 10-Q for the period ended September 30, 2003). |
44
EXHIBIT INDEX
(continued)
|
|
|
Exhibit |
|
|
Number |
|
Description |
10.12*
|
|
Companys Retirement Income Plan for Directors, as last amended
August 1995 (incorporated by reference to Exhibit 10.7 of the
companys Annual Report on Form 10-K for the year ended December
31, 2002). |
|
|
|
10.13*
|
|
Letter Agreement and Employee Agreement, dated as of July 30,
2004, as amended, between the company and R. R. Goodmanson
(incorporated by reference to Exhibit 10.8 of the companys
Quarterly Report on Form 10-Q for the period ended June 30,
2004). |
|
|
|
10.14
|
|
Companys 1997 Corporate Sharing Plan, adopted by the Board of
Directors on January 29, 1997 (incorporated by reference to
Exhibit 10.9 of the companys Annual Report on Form 10-K for the
year ended December 31, 2001). |
|
|
|
10.15
|
|
Companys Bicentennial Corporate Sharing Plan, adopted by the
Board of Directors on December 12, 2001 and effective January 9,
2002 (incorporated by reference to Exhibit 10.12 of the
companys Quarterly Report on Form 10-Q for the quarter ended
March 31, 2002). |
|
|
|
10.16
|
|
Purchase Agreement by and among the company as Seller and the
other Sellers Identified Therein and KED Fiber Ltd. and KED
Fiber LLC as Buyers, dated as of November 16, 2003 (incorporated
by reference to Exhibit 10.12 of the companys Annual Report on
Form 10-K for the year ended December 31, 2003). The company
agrees to furnish supplementally a copy of any omitted schedule
to the Commission upon request. |
|
|
|
10.17
|
|
Amendment to the Purchase Agreement dated December 23, 2003, by
and among the company as Seller and the Other Sellers Identified
Therein and KED Fiber Ltd. and KED Fiber LLC as buyers
(incorporated by reference to Exhibit 10.13 of the companys
Quarterly Report on Form 10-Q for the period ended March 31,
2004). The company agrees to furnish supplementally a copy of
any omitted schedule to the Commission upon request. |
|
|
|
10.18
|
|
Amendment to the Purchase Agreement dated April 7, 2004, by and
among the company as Seller and the Other Sellers Identified
Therein and KED Fiber Ltd. and KED Fiber LLC as buyers
(incorporated by reference to Exhibit 10.14 of the companys
Quarterly Report on Form 10-Q for the period ended March 31,
2004). The company agrees to furnish supplementally a copy of
any omitted schedule to the Commission upon request. |
|
|
|
10.19
|
|
Amendment to the Purchase Agreement dated April 22, 2004, by and
among the company as Seller and the Other Sellers Identified
Therein and KED Fiber Ltd. and KED Fiber LLC as buyers
(incorporated by reference to Exhibit 10.15 of the companys
Quarterly Report on Form 10-Q for the period ended June 30,
2004). The company agrees to furnish supplementally a copy of
any omitted schedule to the Commission upon request. |
|
|
|
10.20
|
|
Master Confirmation Agreement and the related Supplemental
Confirmation dated as of October 24, 2005, between Goldman Sachs
& Co. and the company relating to the companys accelerated
Stock repurchase program (incorporated by reference to Exhibit
10.20 of the Companys Quarterly Report on Form 10-Q for the
period ended June 30, 2006.) |
|
|
|
10.21*
|
|
Letter agreement dated June 16, 2006 between the company and G.
M. Pfeiffer. The company agrees to furnish supplementally a
copy of any omitted attachment to the Commission upon request
(incorporated by reference to Exhibit 10.21 of the Companys
Quarterly Report on Form 10-Q for the period ended June 30,
2006.) |
45
EXHIBIT INDEX
(continued)
|
|
|
Exhibit |
|
|
Number |
|
Description |
12
|
|
Computation of Ratio of Earnings to Fixed Charges. |
|
|
|
31.1
|
|
Rule 13a-14(a)/15d-14(a) Certification of the companys Principal Executive Officer. |
|
|
|
31.2
|
|
Rule 13a-14(a)/15d-14(a) Certification of the companys Principal Financial Officer. |
|
|
|
32.1
|
|
Section 1350 Certification of the companys Principal Executive Officer. The
information contained in this Exhibit shall not be deemed filed with the Securities
and Exchange Commission nor incorporated by reference in any registration statement
filed by the registrant under the Securities Act of 1933, as amended. |
|
|
|
32.2
|
|
Section 1350 Certification of the companys Principal Financial Officer. The
information contained in this Exhibit shall not be deemed filed with the Securities
and Exchange Commission nor incorporated by reference in any registration statement
filed by the registrant under the Securities Act of 1933, as amended. |
|
|
|
* |
|
Management contract or compensatory plan or arrangement required to be filed as an exhibit to
this Form 10-Q.
|
46